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The use of experimental infection models to investigate the 
correlation between clinical and pathological measures of the 
severity of respiratory disease in three species 
Abstract 
The objective of this research was to investigate the relationship between ante mortem 
assessments of disease severity and the gross pathological manifestations of disease 
observed during necropsy. Many clinical assessments are subjective, the hypothesis 
under investigation is that these correlate with the pathological state of the animal. 
Bronchopneumonia due to Pasteurella haemolytica Al in calves, Actinobacillus 
pleuropneumoniae infection in pigs, and Mycoplasma gallisepticum infection of 
chickens were investigated. The diseases were induced by experimental infection and 
animals were closely monitored. For calves and pigs, rectal temperature, respiratory 
rates and clinical demeanour scores were recorded and at necropsy, the respiratory 
tract and any other affected organs examined. For chickens, an auscultated respiratory 
score was used, serological responses were recorded and, upon necropsy, inspection 
of airsac lesions and mycoplasma isolation were performed. 
Both graphical and statistical methods were used to correlate ante mortem measures of 
disease severity with each other and with post mortem measures of gross pathological 
lesions and bacteriological isolation of the infecting organism. Calves showed highly 
correlated relationship between ante mortem and post mortem indicators of disease 
severity. For pigs, the relationship between clinical variables and gross pathology was 
much less clear and varied between the three serotypes of Actinobacillus 
pleuropneumoniae used (serotypes 3,5a, 9). In chickens, there were few clinical 
signs evident until the pathology compromised the physiological reserve capacity of 
the airsacs. Beyond this `threshold', rapid increases in respiratory auscultation score, 
mycoplasma isolation and serological response were all indicators of increasing gross 
pathological changes. 
The relationships between ante mortem assessments of disease severity and the gross 
pathological lesions recorded at necropsy were usually non-linear and differed for 
each pair of variables correlated. The strength of correlation between pairs of 
variables also differed according to the stage of disease progression and severity of the 
infective episode for each of the species studied. The relationships between clinical 
variables being used as indicators of disease severity and the post mortem pathological 
measures need to be clearly understood for each variable before conclusions 
concerning the disease severity, prognosis or, in treated animals, efficacy predictions 
can be made. 
Keywords: clinical score, disease severity, efficacy assessment, experimental infection, respiratory 
disease, Pasteurella haemolytica, Actinobacillus pleuropneumoniae, Mycoplasma gallisepticum 
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CHAPTER 1: INTRODUCTION TO THE THESIS 
Introduction 
The intention of this research is to investigate the assessment of disease severity for 
respiratory infections using experimental infection studies. In the assessment of 
disease severity, scoring systems are routinely used to quantitatively express the 
clinical condition and the clinical progression of animals. There is little literature 
discussing the correlation of clinical scoring systems with pathological measures of 
disease severity. In this research, respiratory diseases have been induced by 
experimental infection. The clinical signs of animals have been recorded and 
correlated with pathological observations upon necropsy. Experimental infections 
were conducted in calves, chickens and pigs, which are the three most economically 
important farm animal species in European agriculture. 
The assessment of overall health status of any living animal is very subjective. 
Individual clinicians ascribe different levels of importance to each disease sign 
(Espinasse et al. 1989). A clinical evaluation depends on a variety of factors 
including the severity, type and duration of different signs, as well as patient-specific 
factors such as age, immune and nutritional status. In human medicine clinical 
scoring has been used as an aid to giving a prognosis e. g. patients infected with 
human immuno-deficiency virus (Vanhems and Toma 1995) as well as an indicative 
diagnostic measure (Park et al. 1991, Herrera and Jepson 1994). In veterinary 
medicine use, according to the literature, is largely restricted to a measure of the 
severity of the disease at a point in time (Ishibashi and Matsumoto 1985, Robb and 
Kronfield 1986), or the clinical response over a period of time (O'Dair et al. 1994, 
Back et al. 1995). The weighting and importance ascribed to each disease sign used 
in constructing a clinical scoring system generally depends upon the experience of the 
clinician (Espinasse et al. 1989). The overall condition of the animal is also an 
important determinant of the impact that any pathological process will have 
(Thrusfield 1995, Reeve-Johnson 1997). 
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The assessment of clinical condition is largely subjective and qualitative. Scoring 
systems provide a method of transposing clinical assessments into more objective and 
quantitative records in order that comparisons between patients, and improvements in 
individual patients can be communicated in scientific literature and between 
clinicians. 
A clinical score is usually a numeric representation of the severity of clinical signs. 
The capacity of a scoring system to grade severity of signs depends upon the scale, 
which in the crudest form is absent or present (0 or 1) e. g. absence or presence of a 
cough or naso-ocular discharge, but may also further attempt to grade severity of signs 
by grouping them into categories of severity e. g. mild, moderate and severe. The 
parameters taken into account when producing a clinical score vary according to the 
body system which is being examined and the number of easily recognisable signs 
which are consistently present and are indicative of the disease under observation. 
Usually there is an underlying assumption in clinical scoring systems that the 
appearance of signs coincide with the pathological progression of disease and that the 
more signs present, the more severe the disease. However, the appearance of overt 
clinical signs does not give a linear and evenly graduated representation of the 
underlying pathological progression. There is little veterinary literature which 
attempts to correlate clinical findings with observed pathology, and no statistically 
valid controlled studies appear to have been conducted. Part of the reason is that, in 
the field, animals are generally monitored until recovery and are not submitted for 
necropsy unless severely diseased. With field cases, which usually are of multi- 
factorial aetiology, unless animals come to necropsy during the acute disease episode, 
pathological changes cannot always be readily ascribed to a particular pathogen or 
even pathological episode. 
In order to better understand how clinical signs reflect the pathological progression of 
respiratory disease, statistical evaluation of the correlation between clinical and 
pathological signs was conducted in three species suffering from distinct respiratory 
conditions, each of significant economic impact to the animal production industry. 
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The conditions investigated were: respiratory pasteurellosis in calves ('shipping 
fever') as caused by Pasteurella haemolytica both in combination with Mycoplasma 
bovis, and as the sole pathogen; in chickens, mycoplasmosis as caused by 
Mycoplasma gallisepticum; and in pigs, Actinobacillosis caused by serotypes 3,5a 
and 9 of Actinobacillus pleuropneumoniae. 
The intent of this work is to develop a better understanding of how clinical scoring 
systems relate to the gross pathology observed at necropsy. Additionally, the 
correlation between these clinical scoring systems and other variables, such as cough 
score in pigs (MacKinnon 1998) or rectal temperature in calves (Scott 1996,1998) 
which have been suggested as being more reliable objective measures of the onset of 




Qualitative clinical scoring systems have long been used by the medical profession as 
a means of communicating the severity of a patient's condition, for a variety of 
diseases e. g. cancer (Karnofsky and Burchenal 1949), lower respiratory tract 
infections (Silverman and Anderson 1956, Kjolhede et al. 1995), bowel conditions 
such as Crohn's disease (Park et al. 1991), eczema (Glover and Atherton 1992), 
malaria (Herrera and Jepson 1994) and HIV (Vanhems and Toma 1995). Quantitative 
indicators of clinical status include temperature, respiratory rate and blood pressure. 
Different scoring systems assess different factors, some concentrating upon single 
signs (Back et al. 1995) and others being based upon a combination of signs 
(Magnaval 1995). 
In veterinary medicine, scoring systems are similarly applied but of necessity are 
adapted according to the species. Consequently, many different systems have been 
used to describe clinical demeanour in animals. The background literature review has 
included examples from pigs (Fedorka-Cray et al. 1993), calves (Gourlay et al. 1989, 
Thomas et al. 1989, Braidwood and Henry 1990, Genicot et al. 1993), adult bovines 
(Collie 1992), horses (Robb and Kronfield 1986, Milne et al. 1994), dogs (Sture and 
Lloyd 1995), cats (O'Dair et al. 1994), and rabbits (Ishibashi and Matsumoto 1985). 
No literature making direct correlations between the ante mortem clinical score and 
gross organ pathology appears to exist. Some authors have commented on the 
`significant heterogenous variance' in clinical scores (Moore et al. 1996) indicating 
the influence that environment, infection pressure, immune status of different groups 
of animals, or even genetic makeup, might have on the clinical condition as assessed 
by a scoring system, but this has not been investigated in relation to pathological 
findings at necropsy. In order for the pathogenesis of disease to be more fully 
understood, clinical trial conditions which can be closely controlled and monitored are 
needed and the ability to gather ante and post mortem data must exist. Experimental 
infection studies which were being developed for the future efficacy testing of 
vaccines and antimicrobials presented such an opportunity. 
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Research Objectives 
Experimental infection studies involving respiratory disease in calves, chickens and 
pigs were conducted. In order to control the type and severity of respiratory disease, 
animals were inoculated with a pre-defined dose of infecting organism by an 
established route of inoculation. The clinical scores and pathological measurements 
were standardised for all trials involving a single species. 
A literature review was conducted to locate disease models which had been 
extensively used and which produced an acceptable level of repeatability, in each of 
the study species. Based upon this review, pilot studies and model development work 
were conducted to ensure that the experimental infection models worked reliably and 
to modify the methodology where appropriate. The author conducted all the literature 
searches, designed the study protocols, supervised and was closely involved with the 
clinical conduct of each study, collated and interpreted the data. Statistical advice was 
sought from specialist statisticians. Staff based permanently on the trial sites were 
responsible for handling non-planned incidents, and these were promptly 
communicated to the author. 
The objectives of this research were: 
1. To reproduce respiratory disease under defined conditions, as caused by distinct 
and economically important pathogens in calves, chickens and pigs. 
2. To monitor the clinical course of these diseases and to quantify the clinical signs of 
subjects by means of pre-determined clinical scoring systems. 
3. To conduct a detailed post mortem inspection of the respiratory tract and any other 
affected organs of animals upon necropsy. 
4. To analyse the correlation between the clinical signs exhibited by animals prior to 
necropsy and the gross pathological signs during necropsy shortly thereafter. 
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Chapter 2: Experimental infection of calves and the evaluation of 
disease severity 
Introduction 
Infectious pneumonia caused by viruses, mycoplasmas and bacteria constitute a major 
problem in countries all over the world. Estimates of economic loss attributable to 
infectious respiratory disease in young cattle have been performed (Thomas 1977, 
Loan 1984, Gourlay et al. 1989, Jones 1992, Virtala et al. 1996a, Reeve-Johnson et al. 
1997b, Esslemont et al. 1998, Reeve-Johnson 1998b). In each case, there were very 
large economic losses in production. Thomas et al. (1978) using data from the Milk 
Marketing Board's beef progeny testing scheme, concluded that enzootic pneumonia, 
pneumonic consolidation and pleurisy together account for the majority of losses from 
fatal disease. Scott (1998) has stated that respiratory disease is the major cause of 
financial loss due to infectious disease in intensively reared cattle units. In 1989, 
enzootic pneumonia in weaned calves was estimated to cost British farmers in excess 
of £50 million annually (Gourlay et al. 1989). Jones (1992) estimated that the viral 
component of respiratory disease was responsible for £60 million annually in the UK. 
Virtala et al. (1996a) using linear regression models demonstrated that pneumonia can 
reduce body-weight gain of female dairy calves by 800g per week during the first 
three months of life which has an additional impact on the age of first calving. Reeve- 
Johnson (1998b) reported that as many as 16 million cattle may be affected annually 
with respiratory disease in Europe and that non-fatal production losses probably cost 
the European cattle industry as much as ECU 576 million annually. Esslemont et al. 
(1998) performed a range of illustrations on the costs of respiratory diseases in dairy 
heifers. With a typical case of 30% morbidity and 5% mortality, the total costs were 
found to amount to £3824-£4732 per 100 cases (£830 for veterinary treatments, £300 
for veterinarian's time, £2240 for depression of the calf's performance and up to 
£1362 for the loss of stockperson's time). 
The aetiology of calf bronchopneumonia is complex and can involve viruses, 
mycoplasmas and bacteria (Dyer 1982, Wikse 1990) as well as managemental and 
environmental factors (Frank 1986, Cole 1996, Grandin 1996, Perino 1996). Primary 
viral infections may independently cause clinical disease, depending on the virus and 
the condition of the host. More importantly, they predispose the animal to secondary 
complications such as bacterial invasion, particularly when other immunosuppressive 
factors are present. Such factors include poor nutrition, stress (e. g due to 
transportation, handling, de-horning and castration) and concurrent disease. The 
immunosuppressive effects of some bovine viral pathogens are manifested in their 
ability to facilitate bacterial colonisation of the lower respiratory tract (Jakab 1984). 
This has been demonstrated with several viruses including bovine herpes virus 1 
(Jericho and Langford 1978), bovine viral diarrhoea virus (Corstvet and Panciera 
1982), para-influenza-3 virus (Baldwin et al. 1967) and bovine respiratory syncytial 
virus (Lehmkuhl and Gough 1977). There is no information about the specific 
immuno-suppressive effects for many of the other viruses isolated from bovine lungs 
such as bovine adenovirus, bovine enterovirus, bovine parvovirus, caronavirus, 
calicivirus, bovine reovirus, bovine rhinovirus, malignant catarrhal fever virus and 
bovine herpes virus 4 (Perin 1996). At present in the UK, the viruses most 
commonly demonstrated in outbreaks of pneumonia are para-influenza 3, respiratory 
syncytial virus, calf coronavirus, bovine herpes virus 1 and bovine viral 
diarrhoea/mucosal disease virus. 
Bacteria, particularly Pasteurella spp., play an important role in many outbreaks of 
calf bronchopneumonia. They increase the severity of the primary lung damage 
caused by viruses and exacerbate the clinical signs, frequently with a fatal outcome, 
due to leukotoxin release. Furthermore, experimental studies indicate that Pasteurella 
haemolytica can act as a primary pathogen, producing severe acute pneumonia in 
calves (Confer et al. 1984, Gibbs et al. 1984, Ames et al. 1985). 
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Chlamydia spp. also play a role as bovine respiratory pathogens. Clinical disease 
resulting from experimental infection with P. haemolytica has been shown to be more 
severe when Chlamydia is added to the challenge (Palotay and Christensen 1959). 
Haemophilus somnus is an important cause of respiratory disease in feedlot cattle in 
North America. Although pnemonia due to this organism is increasingly being 
reported in Europe, enzootic calf pneumonia and pneumonic pasteurellosis remain the 
most important causes of respiratory disease in Europe (Bryson 1996). 
Mycoplasmas have also been demonstrated to play a role in the development of 
respiratory disease. Evidence suggests that they compromise the innate defences of 
the host including the mucociliary escalator, bovine alveoar macrophages and 
neutrophil function (Jarstrand et al. 1975, Thomas et al. 1991, Almeida et al. 1992, 
Reeve-Johnson et al. 1997b, Reeve-Johnson 1998b). A study on the epidemiological 
and pathological characteristics of respiratory tract disease in dairy heifers during the 
first three months of life suggested a synergistic effect between Mycoplasma spp. and 
P. multocida. Mycoplasma spp. were isolated from 75% of animals showing clinical 
signs of respiratory disease and Pasteurella spp. were isolated from 69 percent 
(Virtala et al. 1996b). 
Three experimental infection studies were used to reproduce respiratory 
pasteurellosis in calves due to either Pasteurella haemolytica Type Al on its 
own, or in combination with concurrent Mycoplasma bovis infection. The 
variables measured as indicators of disease severity were: clinical demeanour 
score, respiratory rate, rectal temperature, percent lung consolidation and 
microbiological reisolation. 
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Materials and methods 
Calves aged eight to thirteen days, which had been reared in closed herds, were 
introduced to the experimental animal houses. Room temperatures were 
approximately 20°C and humidity and ventilation were similar for each study. 
Identification of calves was by means of uniquely numbered ear tags. 
At intake, animals were examined for general health and nasopharyngeal swabs 
were examined by bacterial culture for presence of adventitious infection with 
P. haemolytica and M. bovis. Calves were observed closely during the rearing 
period to ensure adequate milk intake and for evidence of incidental diseases. 
Calves were weighed and allocated to individual pens with no direct contact between 
animals. After introducing calves to the experimental animal house, they were fed a 
glucose/electrolyte solution for two feeds before being reared on a reconstituted 
commercial milk replacer powder. Calves were bucket-fed each morning and 
afternoon at the same time and were not fed any additional concentrated feed. Milk 
refusals were scored. 
Once calves were acclimatised, they were experimentally infected according to the 
schedule described for each study. Clinical demeanour scores, rectal temperature, 
respiratory rate, mortality, percent lung consolidation and microbiological reisolation 
were recorded. The studies ended seven days after infection and necropsy was 
conducted on all calves. 
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Measurement of disease severity 
Measurement of rectal temperature has been cited as an objective measure of clinical 
condition in calves. Different authors consider different thresholds for rectal 
temperature to be indicative of bovine respiratory disease. These range from 39.0°C 
(Laurisden et al. 1994) to >40.5°C (Mechor et al. 1988, Gorham et al. 1990, Picavet et 
al. 1991, Morck et al. 1993). Scott (1994,1996,1998) however argues that 39.5°C is 
a valid threshold for detecting early onset of respiratory disease as the cost 
effectiveness of treatment is greater if treatment is initiated once rectal temperatures 
exceed 39.5°C. In this set of studies, rectal temperature was monitored, in conjunction 
with respiratory rate and clinical demeanour score, in an attempt to understand the 
relationship between these variables used as indicators of disease severity. 
Rectal temperature 
Eight clinical thermometers were placed in a water bath at 25°C, 37°C and 45 °C, 
there was little variation between the thermometers, but three which recorded identical 
readings were selected for use in the studies. Rectal temperatures were recorded at 
approximately the same time, in each study, 30 minutes before feeding. 
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Clinical demeanour score 
Through repeated observation of calves, a scoring system was developed which could 
be practically applied to farm situations to grade the overall clinical demeanour of 
calves. A high level of variation was noted between experienced clinicians in 
interpreting disease signs in calves as mild, moderate or severe, and confusion 
between the grading of individual signs as opposed to the overall demeanour of the 
animal was frequent. In an attempt to reduce this, the terms `normal', `subdued', 
`apathy' or `severe disease' were used and further descriptive details were added to 
help classify calves and to attempt to increase the uniformity of application of this 
proposed scoring method (Reeve-Johnson and Otte, 1998). While the majority of 
observations were recorded by the author, for each study an additional observer was 
also trained in using the system. Once familiar with the system, there was a high level 
of consistency when observations were compared with those conducted independently 
but at the same time by the author. 
0 "Normal" Alert calf, responds to presence of observer, 
head turns, ears pricked, bright eyes and lustrous 
coat. No signs of disease evident. 
"Subdued" Less bright and alert than normal calf, may cough 
intermittently or show other signs of disease upon 
careful observation, such as nasal or ocular 
discharges and appetite may be reduced. 
2 "Apathy" Responds slowly to presence of observer, ears 
turned down, coat losing lustre, disease signs 
immediately apparent, such as coughing, nasal or 
ocular discharges, appetite reduced. 
3 "Severe disease" Fails to respond to observer, inappetant. 
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Respiratory rate 
In the first study, this was recorded as a score: 




For interpretation, the intermediate point of these scores was used, and expressed as 
45,55 and 70 beats per minute. It was felt that the preciseness of the measurement 
was being reduced with no increase in ease of recording. Consequently, in Studies 2 
and 3, respiratory rate was measured over a 60 second interval by stopwatch and the 
actual rate recorded. 
Clinical Examinations 
Calves were checked twice daily for signs of ill health throughout the trial. For 
each animal, the clinical demeanour and respiratory rate were recorded and the 
rectal temperature was measured prior to the morning and evening feeds. 
Milk intake records 
The quantity of milk offered was recorded for each calf at each feed (twice daily). The 
volume of any milk not drunk was measured and recorded as a refusal. 
The feed refusals were scored as: 
0 No refusal, all milk consumed within 30 minutes 
1 Milk remaining at 30 minutes but all consumed by next feed 
(9-12 hours) 
2< 50% milk remaining at next feed (9-12 hours) 
3> 50% milk remaining at next feed (9-12 hours) 
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Body weight 
Calves were weighed at the beginning of the study and immediately prior to 
necropsy, to the nearest 0.5kg, in a calf weighing crate which had been validated 
within the three months prior to the study as accurate to at least 0.5kg. 
Procedures at necropsy 
Description of lesions 
At post mortem examination, lungs were excised and pneumonic lesions recorded 
on a standard lung diagram (e. g. consolidation, abcessation, fibrous tagging on the 
lung surfaces, areas of focal necrosis). 
Estimation of percent lung area affected 
The percent pneumonic consolidation was estimated using a grid of 100 squares 
which was placed under the lung and the number of squares underlying affected 
areas of the lung marked and counted. 
Microbiology 
Nasopharyngeal swabs were taken from all calves prior to challenge and cultured for 
Pasteurella spp. and M. bovis. Lung tissue was taken for identification of bacteria and 
mycoplasmas present. 
Samples of tissue were collected from cranial, diaphragmatic and caudal lung lobes. 
All the samples were examined for the presence of bacteria and mycoplasmas. All the 
samples were inoculated on to three media: Colombia 
blood agar (Oxoid), PPLO agar 
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(Difco) enriched with 25 percent inactivated horse serum, 7 percent yeast extract, 400 
µg. ml-' ampicillin, 0.05 percent thallium acetate and 1 percent glucose, and Tween 80 
PPLO agar (the same enriched and selective medium with 0.1 percent Tween 80). 
The bloodplates were evaluated after 24 or 48 hours of incubation at 37°C in a carbon 
dioxide enriched atmosphere. The mycoplasma plates were evaluated after two days 
and, if negative, daily until 14 days after inoculation. 
Animals (Scientific Procedures) Act 1986 
Procedures were carried out under Project licence 90/00780, procedure 14, protocol 
approved by Dr P. G. G. Darke, HO inspector, Swindon, 18 July 1995. Procedure 14 
is classified as moderate. Humane end-points were any calf showing anorexia, 
marked apathy, dyspnoea, rectal temperature >41 °C persisting over a period of 12 
hours. 
Study 1 (CUK9501) calves: 
Study Outline 
Ten male Jersey calves were used in Study 1 
replacer twice daily at 0700hrs and 1800hrs. 
Calves were fed two litres of milk 
Experimental challenge 
Calves were challenged by a trans-tracheal route with P. haemolytica serotype Al, 
isolated from a case of pneumonic bovine pasteurellosis (source: Institute for 
Animal Health, Compton: B756 from calf lung 1090/IAH 141, originally strain 
GC 1 Gourlay and Houghton, 1985) and M. bovis (source: K688 from calf lung 
4171/IAH 333, originally from VIC, Sutton Bonnington, 1992) also from a 
naturally occurring case of calf pneumonia. The inoculum was administered as a 
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20m1 dose being a IOml suspension in culture medium of each microorganism that 
contained 2x10' colony forming units (cfu) of P. haemolytica and 1x108 colorimetric 
colour units (ccu) of M. bovis. A 5cm square patch overlying the trachea one third 
of the way down the neck of each calf was clipped, cleaned and swabbed with 
surgical spirit. A 5cm 18 gauge needle was inserted directly into the tracheal 
lumen, a 20m1 syringe containing the inoculum was attached and the inoculum 
introduced. Before and after inoculation, correct positioning of the needle was 
ascertained by withdrawing the plunger and confirming that air was aspirated into 
the syringe. 
Schedule of study events 
Day 1 Arrival of calves in experimental animal house, general 
health examination, feed with electrolyte glucose 
solution 
Day 2 Start feeding with milk replacer twice daily 
Day 8 Take nasopharyngeal swabs all calves and culture for 
Pasteurella and Mycoplasma 
Day 12 Allocate calves to accommodation, weigh all calves 
Day 15 Trans-tracheal infection with P. haemolytica and M. bovis 
Day 22 Weigh, euthanase and necropsy calves 
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RESULTS 
Colostrum intake, incidental disease and calf management 
Calves weighed between 24 and 31 kg at the beginning of the study. All calves 
lost weight during the study, but the clinical importance could not be statistically 
quantified in the absence of a non-infected control group (Table 1). All ten 
calves experienced diarrhoea and inappetance prior to the start of the trial and 
were treated with oral kaolin (Kaogel, Parke Davis, Pontypool, UK), a 
subcutaneous glucose solution (Calvet no. 8, Animalcare Ltd, Dunnington, UK) 
and oral glucose/electrolyte solution (Lectade) was substituted for milk-replacer 
powder until the calf recovered, which in each case was within 48 hours (by the 
fourth feed). Rotavirus infection was diagnosed by an Enzyme Linked Immuno- 
Sorbent Assay (ELISA) antigen capture kit in faecal samples from calves 1,2,4, 
7 and 8 and this same infection was presumed to be the cause of disease in the 
other five calves. 
Table 1: Start and finish weights of ten calves after experimental infection with 
P. haemolytica and M. bovis. 






Calves euthanased at the end of the study (7 days after infection) 
1 31 28 
3 29 29 
7 24 21 
8 25 23 
10 24 20 
12 24 22 
Calves euthanased before the end of the study (within 24 hours) 
2 29 29 
4 28 27.5 
9 28 28 
11 28 27.5 
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Challenge infection 
Prechallenge nasopharyngeal swabs taken from all ten calves were negative for 
P. haemolytica and M. bovis. The challenge was accomplished satisfactorily in 
nine of the ten calves. Calf 4 struggled immediately after inoculation and 
although the inoculum was presumed to have been delivered satisfactorily this 
could not be ascertained by withdrawal of air from the trachea. The subsequent 
response of this animal and the pneumonic lesions detected at post mortem 
confirmed the success of the inoculation. 
Clinical findings and scores 
All calves coughed intermittently (1-2 min duration) following challenge 
infection. 
Clinical signs in the four animals euthanased before the end of the study 
comprised of pyrexia, inappetance and failure to respond to the presence of the 
observer (clinical score 3, severe disease). Sternal recumbency, tachypnoea 
(respiratory rate above 45 breaths per minute) and inappetance (feed refusal score 
of 3 at last feed) were evident in three of these animals within seven hours of 
challenge. Calf numbers 2,9 and 11 were euthanased at this stage having reached 
the moderate severity band, as defined by the project licence, the fourth animal 
(calf no. 4) that was not recumbent was left for a further 11 hours before being 
killed, by which stage it was recumbent, tachypnoeic and presented with clinical 
demeanour score 3 ('severe disease'). Abnormal clinical signs were not evident 
in five calves for the duration of the trial. Calf no. 12, for which a clinical score of 
3 was recorded, showed inappetance on three occasions but this was unrelated to 
challenge since inappetance had been recorded prior to infection and was related 
to an episode of enteritis and diarrhoea. This calf was clinically healthy by the 
time of euthanasia at the end of the study. 
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Individual animal rectal temperatures, clinical demeanour scores and respiratory 
rates are given in Table 2. Feed refusal scores did not yield any useful data 
because of the peracute nature of the experimental infection. Calves progressed 
from having a full appetite and showing no clinical signs to a clinical condition 
that required euthanasia within a 12 hour period. The last feed refusal score 
therefore often did not relate to the clinical condition. However, all calves which 
required euthanasia and all calves which showed increased demeanour scores or a 
rectal temperature at or above 39.7°C had increased feed refusal scores. Due to 
the small number of calves (4) in this subcategory it would be misleading to 
attempt to correlate this data. Table 3 provides a summary of each parameter 
recorded for each calf in this study. Although clinical score data is ordinal, the 
numeric scale does not reflect a linear disease progression, only a progression in 
easily recognisable signs. Therefore, non-parametric statistical tests based on the 
ranks of the data values rather than the actual numbers recorded were used. 
Graphical illustrations of the relationship between clinical score and rectal 
temperature (Figure 1) and respiratory score and rectal temperature (Figure 2) 
portray the relationships which were statistically tested for strength of correlation 
(Table 18). A two-way table (Table 4) shows the relationship between the two 
clinical scoring systems used (i. e. clinical [demeanour] and respiratory scores). 
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Table 2: Clinical scores, % pneumonic consolidation and recovery of P. haemolytica and M. bovis from lungs of calves experimentally infected with a 
combination of Mycoplasma bovis and Pasteurella haemolytica 
calf no. terminal demeanour % lung reisolation from lung of: 
score consolidation P. haemolytica Mbovis 
Animals surviving to end of stud 
1 0 2 -- 3 0 3 -- 7 0 3 -- 8 0 4 -- 10 0 1 -- 
12 0 4 -- 
mean 2.8 (SD = 1.6) 
Animals euthanased during course of study 
2 3 7 ++ 
4 3 16 ++ 
9 3 7 +- 
11 3 7 +- 
mean 9.25 (SD= 3.9) 
SD = Standard deviation 
+= Positive culture of P. haemolytica or M bovis 
Table 3: Terminal clinical scores and post mortem pathological measures of 
disease severity of ten calves experimentally infected with a combined 
experimental infection of Pasteurella haemolytica Al and Mycoplasma bovis 
CUK9501 Identity Terminal Terminal Percent 
Terminal number of rectal respiratory lung Bacterial 
Score calf temperature rate consolidation reisolation 
(°C) (breaths/minute) 
0 12 38.5 45 4 no 
0 10 38.6 45 1 no 
0 8 38.2 45 4 no 
0 7 38.2 45 3 no 
0 3 38.1 45 3 no 
0 1 38.2 45 2 no 
2 9 39.8 70 7 yes 
3 2 39.8 70 7 yes 
3 4 39.7 70 16 yes 
3 11 39.7 70 7 yes 
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Figure 1: Graphical relationship between ranked rectal temperature and clinical 
score data for ten calves experimentally infected with a combination of 
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N. B. Numbers next to plotted points indicate the number of identical values 
Figure 2: Graphical relationship between ranked respiratory score and rectal 
temperature data for ten calves experimentally infected with a combination of 
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N. B. Numbers next to plotted points indicate the number of identical values 
Table 4: Number of animals with minimum and maximum respiratory scores at 
each clinical score for ten calves experimentally infected with a combination of 
Mycoplasma bovis and Pasteurella haemolytica 






Gross pathological findings 
The mean pneumonic consolidation score for the six calves euthanased seven 
days post challenge was 3% [to 1 significant figure] (Standard deviation = 1.6), 
mean score for the four calves killed 8-19 hours post-challenge was 9% [to 1 
significant figure] (Standard deviation = 3.9) (Table 2). These scores are not 
comparable because of the different duration of infection. The character of the 
lesions between the two groups reflect this incomparability. The three days' 
duration pneumonic lesions showed red/grey hepatisation and a stippled 
distribution. The stellate nature of the lesions indicated resolution, in contrast, the 
7 hour-old lesions were red hepatised, swollen and slightly oedematous. This 
latter type of lesion was most marked and extensive in calf no. 4 that was killed 18 
hours post-challenge. Individual pneumonic lesions were recorded on standard 
lung diagrams. Figures 3,4 and 5 illustrate the relationship between lung 
consolidation data and clinical score, rectal temperature and respiratory rate, 
respectively. 
Figure 3: Graphical relationship between ranked lung consolidation and 
rank of clinical score for ten calves experimentally infected with a 














N. B. Numbers next to plotted points indicate the number of identical values 
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Figure 4: Graphical relationship between rank of lung consolidation and rank of 
rectal temperature for ten calves experimentally infected with a combination of 
Mycoplasma bovis and Pasteurella haemolytica 
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Figure 5: Graphical relationship between rank of lung consolidation and ranked 
respiratory rate data for ten calves experimentally infected with a combination 
of Mycoplasma bovis and Pasteurella haemolytica 
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Microbiological findings 
P. haemolytica was re-isolated from all four of the calves euthanased before the 
end of the study and M. bovis was also isolated from two of these calves (Table 2). 
Neither microorganism was isolated from the six calves which survived to the end 
of the study. The relationship between the clinical score and the bacteriology 
results is expressed in Table 5, and between respiratory score and bacteriology in 
27 
05 10 
Rank of respiratory rate 
Table 6. Table 2 has already shown the relationship between the bacteriology 
results and the lung consolidation data obtained at post mortem examination. 
Table 5: Number of calves at each clinical score from which P. haemolytica was 
successfully re-isolated for ten calves experimentally infected with a combination 
of Mycoplasma bovis and Pasteurella haemolytica 





Table 6: Number of successful bacterial isolations from calves with maximum 
and minimum respiratory scores for ten calves experimentally infected with a 
combination of Mycoplasma bovis and Pasteurella haemolytica 





A summary of results for Study 1 is given in Table 7. Table 8 illustrates the system 
used for the allocation of ranks, whereby each parameter was graded on a scale of 1- 
10. This facilitated cross-group statistical analysis and graphical illustration. 
Table 7: Summary of relationship between terminal clinical scores and mean 
clinical and pathological data of ten calves experimentally infected with a 
combined experimental infection of Pasteurella haemolytica Al and Mycoplasma 
bovis 
Score Number of Mean rectal Mean respiratory Mean % lung % Bacterial 
animals temperature rate consolidation reisolation 
(°C) (breaths/minute) 
0 6 38.3 45 3 0 
1 - - - - - 
2 1 39.8 70 7 100 
3 3 39.8 70 10 100 
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0 12 38.5 0 4 no 3.5 5 3.5 5.5 3.5 
0 10 38.6 0 1 no 3.5 6 3.5 1 3.5 
0 8 38.2 0 4 no 3.5 3 3.5 5.5 3.5 
0 7 38.2 0 3 no 3.5 3 3.5 3.5 3.5 
0 3 38.1 0 3 no 3.5 1 3.5 3.5 3.5 
0 1 38.2 0 2 no 3.5 3 3.5 2 3.5 
2 9 39.8 3 7 yes 7 9.5 8.5 8 8.5 
3 2 39.8 3 7 yes 9 9.5 8.5 8 8.5 
3 4 39.7 3 16 yes 9 7.5 8.5 10 8.5 
3 11 39.7 3 7 yes 9 7.5 8.5 8 8.5 
Discussion (Study 1) 
The difference in clinical demeanour between the calves which required 
euthanasia before the end of the study and those which remained until the end of 
the experiment is illustrated by the terminal clinical demeanor scores (0 or 3, 
Table 2). A difference was also seen in the mean pneumonic consolidation scores 
(2.8 versus 9.25, Table 2) but these are not comparable since the interval to 
euthanasia, and therefore post mortem examination, for the two groups was 
different. However, differences were noted in the character of the macroscopic 
pneumonic lesions. The lesions in the calves killed only seven to 18 hours post- 
challenge were red, hepatised, oedematous and slightly raised whereas in the 
remaining calves, the stippled character of the lesions, the red/grey hepatisation 
and lack of oedema indicated a resolving lesion. The failure to reisolate either 
P. haemolytica or M bovis from these lesions in the calves which survived to the 
end of the study supports the suggestion that the lesions were resolving. 
The experimental infection model appeared to work well in so far as all animals 
showed either clinical or pathological evidence of the experimental challenge. 
P. haemolytica was isolated from all four of the calves euthanased early in the 
study, in addition to M. bovis from two of these calves. 
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The drop in bodyweight seen in five of the six calves which survived to the end 
of the experiment was not statistically significant, though, it is worth noting that 
over a seven day period no calf gained weight. The weight of the calves 
euthanased early in the study did not alter much in the short period that they were 
on the study. Whilst weight loss could be due to inappetance and increased tissue 
catabolism during disease, it could also relate to a reduction in gut fill from the 
pre-infection level when calves had recently received a two litre feed and the final 
weighing which was up to 12 hours after the last feed. The diarrhoea due to the 
rotavirus infection would also contribute towards impaired growth. Furthermore, 
some calves had been inappetant at the last feed. 
Respiratory rate , percent lung consolidation and bacterial reisolation increased as 
clinical score increased (Table 7). A comparison between calves with a terminal 
score of 0 and those with a terminal clinical score of 2 or 3 showed a significant 
increase in each of the above parameters (Kruskal-Wallis test, p=0.05). In this 
study, there seemed to be a rectal temperature threshold above which respiratory 
rate, lung consolidation and bacterial reisolation were significantly increased. This 
threshold temperature appeared to be above 38.6°C and less than 39.7°C (Table 3). 
This is comparable with thresholds cited as indicative of respiratory disease by Bols 
and de Kruif (1994), Lauridsen et al. (1994) and Scott (1994). The scale of the 
graph (Figure 7) does not clearly show the increase in mean rectal temperature by 
1.5°C above normal body temperature as the condition of calves deteriorated from a 
clinical score of 0 to 3 (Table 7). 
An increase in clinical score does not reflect uniform linear increases in other 
clinical signs such as respiratory rate or rectal temperature which increased more 
rapidly in "subdued" or "apathetic" calves initially (i. e. between scores 0-2) than 
for 
calves with higher clinical scores (scores 2 and 3) or for lung consolidation 
(although this later measure was within a narrow range of 1-7% and 7-16% in nine 
of the calves (Figure 7). More data are needed before 
firm conclusions can be drawn 
from this study. 
10 
Overall, an increase in clinical score did appear to correlate to increased lung 
consolidation, and in turn, as might be expected, to both increased respiratory rate 
and isolation of the infecting organism. The inflammatory changes associated with 
lung damage induced by the pathogen would be expected to cause pyrexia. The 
alternative pathway of the complement cascade is activated by the presence of lipo- 
polysaccharide in the bacterial membrane, attracting phagocytes. Necrosis of 
neutrophils, heightened by leucotoxin release, triggers additional release of 
cytokines which not only cause pyrexia but are chemo-attractant to leukocytes and 
increase pulmonary vascular permeability which augments cellular infiltration. 
Consequently, along with cellular infiltration, oedema and consolidation of the lung, 
the rectal temperature also rises. Formal statistical analysis of the strength of these 
relationships is discussed at the end of this chapter in conjunction with the results 
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Study 2- (CBE9501) calves: 
Study Outline 
Sixteen male Friesian-Holstein calves with a mean body weight of 41.4 (± 1.7) kg 
(range 36-44 kg) were experimentally infected intra-tracheally with Pasteurella 
haemolytica type Al (LPB 1419). The calves were fed three litres of milk replacer 
twice daily at 0900hrs and 1800 hrs. 
Schedule of study events 
Day 1 Arrival of calves in experimental animal house, general health 
examination of calves, feed glucose/electrolyte solution, weigh calves 
Day 2 Transportation of calves in closed trucks, start feeding milk replacer 
twice daily 
Day 3 Deep endo-bronchial infection with P. haemolytica Al 
Day 10 Weigh, euthanase and necropsy calves 
Experimental challenge 
On the second day of the trial, the calves were transported in closed trucks for two 
hours and then returned to the animal accommodation. This was done to simulate the 
typical transportation stress experienced by young calves when being transported 
large distances across Europe from their herd of origin to calf raising units. Upon 
arrival at these units, they typically encounter new infection challenges for which they 
may not have adequate passively derived antibody protection from colostrum from 
cows at a different location which had not been exposed to the microbial population at 
the calf's new location. This is a typical time for outbreaks of respiratory 
pasteurellosis. On the third day of the trial, all the calves were inoculated intra- 
tracheally with P. haemolytica type A 1. 
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Experimental infection procedure 
A first-pass culture of P. haemolytica type Al was inoculated into 10 ml quantities of 
brain-heart-infusion broth (Oxoid), enriched with 5 percent fetal calf serum and 
incubated at 37°C in a shaking water bath for six hours. The approximate bacterial 
count of each broth after six hours of incubation was 1x 109 cfu ml-'. A polyethylene 
catheter ('Intramedic', VEL) was inserted through the right nostril and advanced into 
the trachea until it was 5 cm proximal to the bifurcation. The single dose inoculum 
consisted of 5 ml of the six-hour culture of P. haemolytica type Al diluted with 5 ml 
of sterile 0.9 percent sodium chloride. 
RESULTS 
As with the previous study, percent lung consolidation and respiratory rate increased 
with worsening clinical score (Tables 9 and 10). The rate of these changes is not 
linearly proportional. Bacterial isolation showed the same trend, however, a failure of 
isolation in the single calf with a score of 2 accounts for the `saw tooth' shape of the 




Relationship between clinical scores and rectal temperature immediately prior to 
postmortem, and % lung consolidation and bacterial re-isolation from lungs during 
necropsy, for sixteen calves endo-bronchially inoculated with P. haemo/ytica Type Al 
Clinical Identity no. Mean rectal Respiratory % lung Bacteriological 
score of calf temperature rate consolidation reisolation 
°C breaths/minute 
0 5575 39.4 24 0 no 
0 9551 39 32 30 no 
0 3597 39 28 0 no 
0 5071 39.4 24 0 no 
0 7497 39.5 36 30 no 
0 2382 38.6 28 0 no 
1 7144 38.9 52 15 all lobes 
1 6639 40.8 48 30 no 
2 2772 41 60 90 no 
3 2533 40.2 96 80 all lobes 
3 9868 40.4 64 80 all lobes 
3 6720 40.3 84 25 all lobes 
3 5678 40.6 96 80 all lobes 
3 8322 38 52 30 4/6 lobes 
3 4627 39.8 40 10 all lobes 
3 4624 40.1 72 80 negative 
Table 10: Summary of relationship between clinical scores and means of other 
variables for sixteen calves experimentally infected with Pasteurella haemolytica 
Type Al 
Score Number of Mean rectal Mean Mean % lung % Bacterial 
respiratory 
animals temperature rate consolidation reisolation 
0 6 39.2 29 10 0 
1 2 39.9 50 22 50 
2* 1 (41) (60) (90) (0) 
3 7 39.9 72 55 85 
* N. B. only one animal had a score of 2 so mean data may be misleading 
Mortality 




Eight hours after infection, four calves showed pyrexia (40.4 ± 0.2°C). The mean 
rectal temperature of the other calves showed no increase. The relationship between 
ranked rectal temperature and clinical data is illustrated in Figure 7. Apart from two 
calves (calves 7144 and 8322), the other eight calves with a clinical demeanour score 
of one or more had a rectal temperature above 39.7°C. None of the six calves with a 
clinical demeanour score of 0 had a rectal temperature above 39.5°C. 
Figure 7: Graphical relationship between rectal temperature and ranked clinical 
data for sixteen calves experimentally infected with Pasteurella haemolytica Type 
Al 
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Respiratory rate 
Eight hours after the experimental infection, all the calves were tachypnoeic (range 
52-105). The respiratory rate of eight calves remained elevated until they were 
euthanased for welfare reasons. The mean respiratory rate of the other eight calves 
had returned to normal on the second day after inoculation. In four of these calves, 
there was a relapse of signs and the mean respiratory rate increased again on the 
seventh day after the inoculation and remained elevated (above 60 breaths per minute) 
until the end of the study. The relationship between respiratory rate and clinical score, 
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and respiratory rate and rectal temperature is illustrated in Figures 8 and 9, 
respectively. 
Figure 8: Graphical relationship between ranked respiratory rate and ranked 
clinical score data for sixteen calves experimentally infected with Pasteurella 













N. B. Numbers next to plotted points indicate the number of identical values 
Figure 9: Graphical relationship between ranked respiratory rate and ranked 
rectal temperature data for sixteen calves experimentally infected with 
Pasteurella haemolytica Type Al 
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Respiratory type 
The euthanased calves were all tachypnoeic (> 45 breaths per minute) and were also 
severely dyspnoeic eight hours after the infection. Their respiratory type remained 
very laborious until they were euthanased. In the other calves, the respiratory type 
was tachypnoeic and some showed signs of dyspnoea eight hours after the inoculation 
but returned to normal within 24 hours of the inoculation. Some of these calves 
coughed and purulent nasal discharges were apparent after the infection but there were 
no other clinical signs. In eight calves, the clinical score increased again nine days 
after the infection and remained increased until the end of the trial. 
Appetite 
All the calves had a severely reduced appetite eight hours after the infection (appetite 
scores 2 and 3). The appetite of the calves which showed a relapse in clinical signs 
was more reduced (score 3) than calves which made a full recovery from the sixth day 
after the inoculation until the end of the trial (score 2). All calves which were 
euthanased before the end of the study had feed refusal scores of 3. No calves 
exhibited appetite score 1. If all of the milk replacer was not drunk within a short 
time of feeding (< 30 minutes), the calves did not show any further interest in 
drinking it. This is probably partly due to the fall in temperature of the milk replacer 
solution from 35-40°C at feeding time to room temperature, which makes it less 
appetising for the calf. 
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Post mortem examination 
Macroscopic pathology 
Calves euthanased before the end of the study 
In five of the calves, the lung lesions were severe and abundant and involved all lung 
lobes, 80-90 percent of the surface area of the lungs showed changes. The lesions 
were characterized by red and grey hepatisation, oedema, necrosis and fibrosis. The 
cranial and middle lung lobes were most severely affected. The caudal lung lobes 
were also affected but to a lesser extent. 
One calf which was euthanased within 24 hours of inoculation had only moderate 
lung lesions, involving 15 percent of the surface area of the lungs. The two calves, 
euthanased on Days 4 and 6, had only moderate lung lesions compromising 10 and 30 
percent of the lung area but a severe catarrhal enteritis. 
Calves surviving until the end of the study 
Three of the eight calves which were examined at the end of the study had no lung 
lesions. Two had only moderate lung lesions involving 30 percent or less of the lung 
area. In the remaining three calves (Table 9), moderate to abundant lung lesions were 
evident. In one of them, less than 30 percent of the lungs were affected, presenting 
red and grey hepatisation in the right apical and middle lung lobes. Figures 10,11 and 
12 illustrate the relationship between lung consolidation and clinical score, rectal 
temperature and respiratory rate respectively. 
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Figure 10: Graphical relationship between ranked lung consolidation and 
ranked clinical score data for sixteen calves experimentally infected with 
Pasteurella haemolytica Type Al 
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Figure 11: Graphical relationship between ranked lung consolidation and 
ranked rectal temperature data for sixteen calves experimentally infected with 
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Figure 12: Graphical relationship between ranked lung consolidation and 
ranked respiratory rate data for sixteen calves experimentally infected with 
Pasteurella haemolytica Type Al 









N. B. Numbers next to plotted points indicate the number of identical values 
Bacteriology 
Calves euthanased during the study 
P. haemolytica type Al was isolated from all the lung samples of the seven of the 
eight calves euthanased during the experiment. A haemolytic E. coli (VTEC) was 
isolated from the jejunum, colon and mesenteric lymph nodes of a calf euthanased on 
day 9 of the study. No P. haemolytica was reisolated from calf 2772, euthanased 
during the study. 
Calves euthansed at the end of the study 
No bacteria were isolated from any of the lung samples. The relationship between 
clinical score and bacteriological reisolation is illustrated in Table 11. 
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Table 11: Number of animals from which P. haemolytica was successfully 
reisolated at each clinical score for sixteen calves experimentally infected with 
Pasteurella haemolytica Type Al 
number of Clinical score 





Table 12 provides the individual animal data before infection and at the last 
measurement prior to necropsy. Table 13 shows the terminal clinical and pathological 
data and ranked data which was used to portray the gradations in measured variables 
on the same scale to enable the calculation of correlation coefficients between each 
combination of clinical and pathological measures and their comparison. 
Table 12: Individual animal data before infection and at last measurement prior 
to necropsy (CBE9501) for calves experimentally infected with Pasteurella haemolytica 
Type Al 
CBE9501 Before infection Terminal measurements prior to necropsy 
Calf Rectal Resp. Mean clinical Rectal Respiratory Mean clinical Lung 
No Temp. rate score Temperature rate score consolidation 
9868 38.9 29 0 40.4 64 1 80 
5678 39.3 33 0 40.4 92 2.5 80 
6720 39.2 32 0.1 40.3 84 3 25 
2533 39.9 34 0.8 40.2 90 3 80 
2772 39.7 35 0 39.5 46 0 90 
7497 38.7 28 0 39 30 0 30 
4624 39.1 39 0 39.6 59 1 80 
2382 39.1 32 0 38.9 45 0 0 
8322 38.9 31 0 39.1 36 1 30 
4627 38.8 36 0 38.9 35 1 10 
5575 39.1 28 0 39 29 0 0 
9551 39.1 32 0 39.3 49 0 30 
7114 39.3 32 0 38.9 52 0 15 
3597 38.6 31 0 39.1 34 1 0 
6639 38.8 30 0 39.3 39 0 30 
5071 39.4 32 0 39.2 33 0 0 
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0 5575 39.4 24 0 no 3.5 6.5 1.5 2.5 5 
0 9551 39 32 30 no 3.5 4.5 5 9.5 5 
0 3597 39 28 0 no 3.5 4.5 3.5 2.5 5 
0 5071 39.4 24 0 no 3.5 6.5 1.5 2.5 5 
0 7497 39.5 36 30 no 3.5 8 6 9.5 5 
0 2382 38.6 28 0 no 3.5 2 3.5 2.5 5 
1 7144 38.9 52 15 yes 7.5 3 9.5 6 13 
1 6639 40.8 48 30 no 7.5 15 8 9.5 5 
2 2772 41 60 90 no 9 16 11 16 5 
3 2533 40.2 96 80 yes 13 11 15.5 13.5 13 
3 9868 40.4 64 80 yes 13 13 12 13.5 13 
3 6720 40.3 84 25 yes 13 12 14 7 13 
3 5678 40.6 96 80 yes 13 14 15.5 13.5 13 
3 8322 38 52 30 yes 13 1 9.5 9.5 13 
3 4627 39.8 40 10 yes 13 9 7 5 13 
3 4624 40.1 72 80 no 13 10 13 13.5 5 
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Discussion (Study 2) 
The results described in this study are similar to earlier observations and demonstrate 
that P. haemolytica type Al is capable of producing severe acute pneumonia in 
conventionally reared calves (Gibbs et al. 1984, Ames et al. 1985) after experimental 
inoculation. The development of clinical signs, gross pathological lesions and 
bacteriological findings were very similar to those reported in clinical cases of 
'shipping fever' (Allan et al. 1983, Gibbs et al. 1983). With more animals there would 
have been more likelihood of successful bacterial reisolation at post mortem 
examination of calves scored as "apathetic" (i. e. clinical score 2). 
There was an increase in rectal temperature of 0.7 °C between clinical scores 0 and 1 
but no further increase in rectal temperature at clinical score 3 (Table 10). However, 
calves even with clinical score 0 had a higher rectal temperature (mean 39.2°C) than in 
the previous study (mean 38.3°C) . 
Although the magnitude of increase in 
temperature as clinical score increased was less than in the previous study, the calves 
were more pyrexic (mean temperature of 39.9°C at score 3 compared to 39.8°C in the 
previous study - the single calf with a clinical score of 2 had a terminal rectal 
temperature of 41.0°C in comparison with a mean of 39.8°C for calves with a score of 
2 in the previous study). The respiratory rate and lung consolidation progressively 
increased with increasing clinical score (Tables 9 and 10). 
Figure 13: 
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The disease produced by this model appeared to be more severe than in the previous 
study in terms of the proportion of calves with a high clinical score, mean percentage 
lung consolidation, and mean rectal temperature. This greater severity may be due to 
the deep endobronchial infection technique (compared to the trans-tracheal technique 
used previously). The infection doses were similar to the first experiment, however 
the simulanteous Mycoplasma bovis inoculation might have been expected to act as 
additional facilitating factor and heighten the disease severity in the previous study. 
Each of these studies was designed to consider separate scenarios: one, the effect of 
combined Mycoplasma and Pasteurella infection and the other the effect of 
transportation stress prior to infection. Experience in repeatedly using the same 
experimental infection model, however, has shown that even with the same infection 
technique and doses, there can be a great deal of variation in the results obtained 
(Reeve-Johnson, 1998a). 
Overall, as in the previous study, an increase in clinical score was related to increasing 
lung consolidation, increasing respiratory rate and bacterial isolation rate. As before, 
rectal temperature and clinical score, and rectal temperature and respiratory rate were 
positively correlated. The results in this study were generally supportive of a 
temperature threshold in the region of 39.7°C as being indicative of the onset of 
respiratory disease, in accordance with other published recommendations by Bols and 
de Kruif (1994), Lauridsen et al. (1994), and Scott (1994). Formal statistical analysis 
of the strength of correlation is discussed at the end of this chapter in conjunction with 
data from the other studies. 
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Study 3- (CFR9501) Calves 
Overview 
Twenty-four Holstein-Friesian or Salers cross calves (6 female and 18 male) with an 
average weight of 39.8 kg were used in the study. All calves were inoculated on days 
4,5, and 6 with a suspension of Pasteurella haemolytica Type Al by a combination 
of intra-tracheal and intra-nasal routes designed to simulate the reinfection patterns 
encountered from `in contact' animals under commercial housing conditions. 
Schedule of study events 
Day 0 Arrival of calves, general health inspection, feed 
electrolyte/glucose solution, weigh all calves 
Day 1 Start feeding with milk replacer 
Day 4 am Intra-nasal infection of all calves 
pm Intra-tracheal infection of all calves 
Day 5 am Intra-nasal infection of all calves 
pm Intra-tracheal infection of all calves 
Day 6 am Intra-nasal infection of all calves 




Seven calves were euthanased during the course of the study due to severe respiratory 
disease. 
Rectal temperature 
At the beginning of the study, prior to the first infection, the mean rectal temperature 
for the group based on an average of the morning and afternoon readings was 39.9°C 
(Standard deviation 0.85). After the initial infection, this rose to 40.3°C on the 
evening after the day of infection (Standard deviation 0.89), however, if the morning 
temperature is also taken into account, the daily mean was at 39.9°C (Standard 
deviation 1.0). In 17 of the calves, the temperature declined over a period of 4 days to 
the initial pre-infection readings. In all seven calves which were euthanased before 
the end of the study, the temperatures continued to rise. In calf 10, a maximum 
temperature of 42.2°C was recorded, but this had declined to 39.5°C by the time of 
necropsy. It was noted that there was regular diurnal variation of the rectal 
temperature. Rectal temperatures tended to be higher in the evenings than in the 
morning (Figure 14). 
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Figure 14: 
Variation in mean morning and mean evening rectal 
















A rise in respiratory rate was noted in all calves after the first inoculation day. The 
pre-infection mean was 28 breaths per minute on the evening of the first day of 
infection and the day after, the mean was 60 breaths per minute. 
The relationship between respiratory rate and temperature is illustrated in Figure 15. 
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Figure 15: Graphical relationship between ranked respiratory rate and ranked 
rectal temperature data for twenty-four calves experimentally challenged with 
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Milk consumption 
There was an immediate decline in milk intake after challenge, however intake 
gradually improved as recovery from infection progressed. 
Clinical scores 
The clinical demeanour score in all calves was increased immediately after challenge 
and did not decline in the seven calves which were euthanased; in the other 17 calves 
it decreased to pre-infection levels by the end of the study. The relationship between 
rectal temperature and clinical score is illustrated in Figure 16. 
48 
Figure 16: Graphical relationship between ranked rectal temperature and 
ranked clinical score data for twenty-four calves experimentally infected with 
repeated Pasteurella haemolytica Type Al challenges 
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Weight of calves 
There were no mean changes in body weight of calves, the trial period was too short 
for sufficient weight loss to occur and the period of reduced milk intake was short. 
Calves drinking the least milk were usually those euthanased during the study and 
therefore they were weighed sooner after experimental challenge than the surviving 
calves. 
Pathology results 
Tables 14 and 15 summarise the lung consolidation observed at necropsy, while 
Figures 17 and 18 illustrate the relationship between lung consolidation and clinical 
score, and lung consolidation and respiratory rate respectively. 
49 
Figure 17: Graphical relationship between ranked lung consolidation and 
ranked clinical score data for twenty-four calves experimentally infected with 
repeated Pasteurella haemolytica Type Al challenges 
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Figure 18: Graphical relationship between ranked lung consolidation data and 
ranked respiratory rate for twenty-four calves experimentally infected with 
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Microbiological results 
The number and percentage of calves in each clinical score banding from which 
P. haemolytica or P. multocida were isolated from the lung is shown in Table 16. 
Individual animal results are given in Table 14. A two-way table (Table 14) 
summarises the relationship between clinical score and bacterial re-isolation. 
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Table 14: Number of successful reisolations of P. haemolytica from calves at each 
clinical score for twenty-four calves experimentally infected with repeated 
Pasteurella haemolytica Type Al challenges 





Table 15: Relationship between clinical scores and other variables used to 
measure severity of disease for twenty-four calves experimentally infected with 
repeated Pasteurella haemolytica Type Al challenges 
T5CCFR Animal Terminal 
rectal 
Respiratory % lung Bacterial 
Clinical score number temperature rate consolidation reisolation 
1 1 40.1 48 15 yes 
1 2 37.5 20 1 yes 
1 5 38.6 18 2 no 
1 6 39.9 20 9 yes 
1 8 37.7 20 6 no 
1 9 39.0 34 16 yes 
1 10 39.5 24 6 yes 
1 13 39.4 30 1 no 
1 7 37.5 18 6 no 
1 14 39.0 30 5 no 
1 15 37.6 20 8 no 
1 17 38.9 18 0 no 
1 19 38.5 24 13 no 
1 20 38.0 24 2 yes 
1 22 39.9 31 5 yes 
1 23 37.8 20 7 no 
1 24 41.2 35 12 yes 
2 18 39.8 81 14 yes 
3 3 38.8 28 12 yes 
3 4 37.1 18 8 yes 
3 11 39.9 97 20 yes 
3 12 38.9 19 19 yes 
3 16 39.0 89 12 yes 




Table 16: Summary of relationship between clinical scores and mean rectal 
temperature, mean respiratory rate, mean percentage lung consolidation and 
percentage bacterial reisolation for twenty-four calves experimentally infected 
with five Pasteurella haemolytica Type Al challenges 
Clinical Number of Mean rectal Mean Mean % lung % Bacterial 
respiratory 
score animals temperature rate consolidation Reisolation 
1 17 38.8 24 6.3 47 
2 1 39.8 81 14 100 
3 6 38.5 49 15.3 100 
Table 17: Summarised clinical, pathological and ranked data for twenty-four 
calves experimentally infected repeatedly with intra-nasal and intra-tracheal 



























1 1 40.1 48 15 yes 9 23 21 20 17 
1 2 37.5 20 1 yes 9 2.5 8 2.5 17 
1 5 38.6 18 2 no 9 10 2.5 4.5 5 
1 6 39.9 20 9 yes 9 21 8 14 17 
1 8 37.7 20 6 no 9 5.5 8 9 5 
1 9 39.0 34 16 yes 9 15 18 21 17 
1 10 39.5 24 6 yes 9 18 12 9 17 
1 13 39.4 30 1 no 9 17 15.5 2.5 5 
1 7 37.5 18 6 no 9 2.5 2.5 9 5 
1 14 39.0 30 5 no 9 15 15.5 6.5 5 
1 15 37.6 20 8 no 9 4 8 12.5 5 
1 17 38.9 18 0 no 9 12.5 2.5 1 5 
1 19 38.5 24 13 no 9 9 12 18 5 
1 20 38.0 24 2 yes 9 8 12 4.5 17 
1 22 39.9 31 5 yes 9 21 17 6.5 17 
1 23 37.8 20 7 no 9 7 8 11 5 
1 24 41.2 35 12 yes 9 24 19 16 17 
2 18 39.8 81 14 yes 18 19 22 19 17 
3 3 38.8 28 12 yes 21.5 11 14 16 17 
3 4 37.1 18 8 yes 21.5 1 2.5 12.5 17 
3 11 39.9 97 20 yes 21.5 21 24 23 17 
3 12 38.9 19 19 yes 21.5 12.5 5 22 17 
3 16 39 89 12 yes 21.5 15 23 16 17 
3 21 37.7 44 21 yes 21.5 5.5 20 24 17 
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Discussion (Study 3) 
The experimental infection model used in this study has been used extensively to 
determine a variety of pathological phenomena relating to Pasteurella infections 
(Espinasse et al. 1989,1990a, 1992a, 1993). It has also been used to determine 
pharmacological parameters in sick calves and to evaluate the efficacy of antibiotic 
and anti-inflammatory products (Espinasse et al. 1990b, 1992b, 1992c). The model 
has been proven to be reliable in its reproduction with consistent signs and severity of 
respiratory infection. 
The percent lung consolidation increased as the clinical score increased. Due to the 
single calf with score 2 and no calves with score 0, it is difficult to interpret the 
gradation in signs. Most data are for calves of score 1 and 3 (Tables 16 and 17). 
Parameters which increased as clinical score increased from 1 to 3 were: mean 
respiratory rate, percent lung consolidation and percent bacterial reisolation (see Table 
17). The single calf with score 2 had a rectal temperature and respiratory rate above 
the means for the 6 calves with score 3. This may be an example of a marginal calf 
being classified as score 2 where it might also have qualified as score 3. This is a 
reflection of the subjectivity which is always present in any `clinical impression', 
even when converted into a score. It could also be that the rectal temperature and 
respiratory rates may decline as homeostatic control is lost in severely ill calves. 
However, with data from only a single animal, this could be misleading. 
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Statistical analysis and discussion of calf study results 
Five variables from three studies were available for analysis: 
Clinical score (0,1,2 or 3) 
Rectal temperature (degrees C) 
Respiratory rate (breaths per minute) 
Lung consolidation (%) 
Bacteriological reisolation (0=no, 1=yes) 
For the first three of these parameters, the last clinical record prior to post mortem 
examination was used in the correlation analysis. In study CUK9501, respiratory 
score (0,1,2 or 3) was recorded instead of respiratory rate. 
The results presented consist of correlation coefficients and p-values for each pair of 
variables. In each case, Spearman's correlation coefficient was calculated, i. e. given n 
pairs of observations (x; , y; ) (i=1,2,..., n) 
for two variables x and y the coefficient is: 
e= 
Il 




where r; denotes the rank of x;, s; denotes the rank of y;, and r ands denote the mean 
values of the ranks of x and y respectively. The p-value was obtained by calculating 
the probability of obtaining a correlation at least as big as the one observed for the 
given number of observations, under the hypothesis of there being no relationship 
between the two variables. This was done automatically using the CORR procedure 
in the SAS for Windows (Version 6.12) package. 
In each study, there were significant correlations between clinical demeanour score 
and both lung consolidation and bacteriological reisolation 
(p<0.05). Some of the 
correlations between other variables revealed greater 
differences between the studies, 
e. g. clinical demeanour score with rectal temperature. 
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On pooling the data, there were significant differences between the three studies in the 
relationships between the variables. Hence, calculating correlation coefficients for the 
combined data is not appropriate, and so these results have not been presented. 
Spearman's correlation coefficients have been used, as most of the parameters were 
ordinal but not on a meaningful numeric scale. Hence, non-parametric tests based on 
the ranks of the data values rather than the actual numbers recorded are more 
appropriate. Although the use of correlation coefficients with some of the variables is 
not statistically very meaningful, e. g. correlations involving bacteriological reisolation 
(recorded as yes or no), the p-values obtained were similar to those from analyses 
more appropriate to this type of data. For example, correlating a continuous variable 
such as rectal temperature with bacteriological reisolation could be considered as a 
two-sample comparison, comparing the average temperature for when bacteriological 
reisolation is `yes' and when it is 'no'. Although an appropriate form of analysis, 
such as a t-test or Wilcoxon Rank-Sum test, would not yield a correlation coefficient, 
the p-values from the two-sample tests are similar to the p-value obtained from the 
Spearman's correlation coefficient that has been used. The correlation coefficients 
involving bacteriological reisolation and other binary responses have been left in for 
the sake of consistency. 
In the situation where there are no tied ranks, the version of Spearman's correlation 
coefficient used can be simplified to the alternative expression: 
tr 
61 d; 2 
r=1- 
n3 -n 
where d; denotes the difference in ranks for the it, pair of observations. 
In the situation 
where tied ranks are present, using this simplified version would cause the correlation 
coefficents to be slightly biased, and hence the product-moment 
formula applied to 
the ranks has been used throughout. The asymptotic 
distributions used to obtain the 
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p-values are less reliable when there are tied ranks, but in general the results are 
similar to those that would be obtained using exact methods. 
Combined study results 
Table 18: Spearman's correlation coefficients for clinical and pathological 
parameters in calves with experimentally induced pneumonic pasteurellosis 
Study Correlation coefficient Clinical Rectal Respiratory % lung 
(p-value) score temperature rate consolidation 
1. CUK9501 Rectal temperature 0.82 (0.004) - - - (n=10) Respiratory rate 0.98 (<0.001) 0.87 (0.001) - - 
% lung consolidation 0.86 (0.001) 0.69 (0.03) 0.87 (0.001) - 
Bacteriological reisolation 0.98 (<0.001) 0.87 (0.001) 1.00 (<0.001) 0.87 (0.001) 
2. CBE9501 Rectal temperature 0.46 (0.07) - - - 
(n=16) Respiratory rate 0.86 (<0.001) 0.58 (0.02) - - 
% lung consolidation 0.61 (0.01) 0.65 (0.007) 0.79 (<0.001) - 
Bacteriological reisolation 0.76 (<0.001) 0.10 (0.72) 0.64 (0.007) 0.24 (0.38) 
3. CFR9501 Rectal temperature -0.06 (0.78) - - - 
(n=24) Respiratory rate 0.28 (0.18) 0.62 (0.001) - - 
% lung consolidation 0.59 (0.002) 0.25 (0.25) 0.52 (0.009) - 
Bacteriological reisolation 0.49 (0.01) 0.37 (0.07) 0.48 (0.02) 0.48 (0.02) 
N. B. Numbers highlighted in bold are significant to p<0.05 
Numbers in brackets are the confidence interval 
In the table of results (Table 18), correlations significant at the 5 percent level have 
been highlighted in bold. In all three studies, most of the pairwise correlations were 
significant. Consistent relationships between variables were particularly noticeable in 
study CUK9501, but the small number of data values in this study should be taken 
into account. Respiratory rate was correlated with rectal temperature, lung 
consolidation and bacterial reisolation in each study, but the level of correlation 
showed some variation between studies. Clinical demeanour score and respiratory 
rate showed significant correlation in two of the studies (p<0.05), although not 
in the 
third. There was only a single animal with a clinical score of 2 which had a very high 
terminal respiratory rate, above the mean respiratory rates for animals of score 1 or 3. 
If the data from this single data point are regarded as out-lying, the mean respiratory 
rate increases from 24 to 49 breaths per minute 
for the 17 animals with a score of 1 to 
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the six animals with a score of 3 and there would be a statistically significant 
correlation between clinical demeanour score and respiratory rate. 
Clinical demeanour score and lung consolidation correlated consistently, indicating 
that the pathology evident in the diseased lung directly contributes to the clinical 
condition of the animals with this respiratory disease. 
Clinical score and bacteriological reisolation also correlated consistently. It is 
surprising that there appears to be better correlation with bacterial reisolation and 
clinical score than clinical score and rectal temperature. This may be due to the 
release of inflammatory mediators which, although not causing pyrexia, cause 
deterioration in the clinical condition of animals or, in addition, due to the association 
of bacterial presence with the quantity of pathological changes in the lung which 
result in the consequent physiological compromise, reflected by the worsening of 
clinical condition. 
Clinical score and respiratory rate showed consistent correlation. Respiratory rate 
correlated significantly with both lung consolidation and bacterial reisolation in all 
three studies. In composite scoring systems, respiratory rate is often considered to be 
an integral part of the overall clinical demeanour (e. g. Espinasse et al. 1989). 
There was no direct correlation between clinical demeanour score and rectal 
temperature in two studies. The explanation for this is best understood in light of the 
non-linearity seen graphically when clinical scores are plotted against rectal 
temperature (Figure 20). Although it appears that initially there is good correlation 
between clinical score and rectal temperature, at high clinical scores the positive 
correlation ceases, presumably due a loss of homeostatic control of temperature 
in 
severely ill animals (score greater than 2). This is a feature in cattle with severe 
endotoxaemia, e. g. cows with E. coli mastitis characteristically may show signs of 
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Mean rectal temperature plotted against mean clinical 
demeanour score for each of three experimental infection 
studies in young calves involving P. haemolytica, 
and in one study (CUK9501) M. bovis infection. 
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N. B. there were no calves with a terminal clinical demeanour score of 0 in Study 3 (CFR9501) 
Rectal temperature correlated significantly with respiratory rate, and in two of the 
three studies with lung consolidation. The lack of significant correlation between 
rectal temperature in two of the three studies with bacterial reisolation may reflect the 
importance of the duration that the infection and pathology has been present. Pyrexia 
is a reflection of the activity of the acute inflammatory response. Bacterial reisolation 
did not correlate with lung consolidation in one study, possibly for the same reason 
that, in an inoculation study, large numbers of bacteria are rapidly introduced into the 
lung, the consolidation, or pyrexic response that might be expected in a field case with 
a similar bacterial infection load would probably not have had sufficient time to 
develop with this type of study. 
Whilst the relationship between rectal temperature and the progression of other 
clinical and pathological signs was non-linear, the data could be 
interpreted that 
certain threshold rectal temperatures were strongly indicative of 
disease. This 
threshold appears to be above 39.5°C, as this was the maximum rectal temperature 
for 
any calf with a `normal' clinical demeanour score of 
0. However, there were several 
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calves with higher clinical demeanour scores which had rectal temperatures lower 
than 39.5°C. The conclusion is that any calf with a rectal temperature above 39.5°C 
can be defined as `diseased', but a rectal temperature lower than 39.5°C does not mean 
that the calf is not diseased. These findings support those of Scott (1994,1996,1998), 
with the caveat that calves with a rectal temperature below 39.5°C should not be 
considered out of risk. This threshold is still of practical use, however, as these 
studies showed that calves with rectal temperatures below 39.5°C, but diseased as 
evidenced by pathological and clinical evidence, had positive clinical demeanour 
scores. The combination of rectal temperature monitoring and observation of animals 
for clinical signs should therefore be a practical method of detecting animals with 
respiratory infections associated with P. haemolytica. The data indicate that the high 
rectal temperature thresholds which some workers have recommended, for example 
>40.5°C (Mechor et al. 1988, Gorham et al. 1990, Picavet et al. 1991, Morck et al. 
1993) would not detect the majority of diseased calves. Across the three studies, out 
of 16 calves with `severe disease' (i. e. a clinical demeanour score of 3) only one had a 
rectal temperature above 40.5°C. Only one of the three calves with an `apathy' 
clinical demeanour score 2 had a rectal temperature above 40.5°C. Two out of the 19 
calves with a `subdued' clinical demeanour score of 1, had a rectal temperature above 
40.5°C. 
The three studies differed in infection technique, dose and route of infection, and in 
one case a combination of infecting organisms was used. Consistent trends in the 
relationships between clinical and pathological data in individual studies, despite 
different infection methodologies, suggests that under different clinical disease 
scenarios, similar relationships might be expected. 
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Chapter 3: Experimental infection of chickens and the evaluation 
of disease severity 
Introduction 
In poultry, respiratory disease due to mycoplasma infection is a significant cause of 
production loss in the absence of treatment (Le Turdu et al. 1984, Dudouyt 1987). 
Mycoplasmas, which belong to the class Mollicutes, are the smallest self-replicating 
procaryotes. Twenty-four species of the genus Mycoplasma have been recovered 
from avian sources, but only four have been established as pathogens for domestic 
poultry, namely, Mycoplasma gallisepticum and Mycoplasma synoviae for chickens 
and turkeys, Mycoplasma meleagridis for turkeys and Mycoplasma iowae for turkey 
embryos. The pathogenicity of other species has not been demonstrated except under 
experimental conditions (Jordan 1990). In many parts of the world, Mycoplasma 
gallisepticum infection remains a primary cause of respiratory disease and is 
responsible for chronic respiratory disease (CRD) in chickens. Infection is 
transmitted by direct contact or via the air to birds in close proximity. There are 
variations in clinical signs but these often include "snicking"', in some cases swollen 
infra-orbital sinuses from which exudate can be expressed, and increased flock 
mortality. Clinical outbreaks may be precipitated by a number of viral causes (Boden 
1993). Secondary infection with Escherichia coli is frequent, and is largely 
responsible for the perihepatitis and pericarditis often seen in mycoplasma-infected 
birds. Mycoplasma are fragile organisms and do not survive for protracted periods in 
a hostile environment (Bradbury et al. 1996), which causes inevitable problems in 
their transport for culture and reisolation. 
Typical gross pathology involves the infra-orbital sinuses and changes to the airsacs. 
The airsacs are transparent in the healthy subject but with Mycoplasma 
infection, they 
become progressively opaque, neo-vascularised, the walls thicken with inflammation, 
' This characteristic clinical sign is a wide gaping of the beak, accompanied 
by a coughing motion with 
a clicking sound 
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nodules of purulent material may form in them and the walls may become lined, %N ith 
purulent material (Figures 1 to 5). 
Typical pathological signs may be masked by supra-infection with secondary 
organisms such as environmental E. coli or Aspergillusfumigatus (Boden 1993). 
Maintenance of birds in tightly controlled environments, and infecting them with pure 
Mycoplasma gallisepticum is the most practical way of assessing the primary 
pathology and clinical signs due to infection with this organism. 
The disease is considered to be an important problem for broilers and economic losses 
are significant: up to 20-30 percent reduction of weight gain, 10-20 percent decrease 
of feed conversion efficiency, 5-10 percent mortality and 10-20 percent condemnation 
of carcasses at processing (Kempf, I., 1998 -personal communication). In 1986, 
poultry meat accounted for 23.6 percent of all meat consumed in the world, 19.4 
percent of meat consumed in Europe and 37.8 percent of meat consumed in North 
America (Anon 1993). Any disease impairing production therefore has the potential 
to cause massive economic losses. 
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Materials and Methods 
The study was conducted using experimentally-induced Mycoplasma gallisepticum 
infection in specific-pathogen-free chickens, using 36 replicated pens of 10 birds. At 
6 days of age, ten birds were allocated to each of 36 pens. Birds were distributed so 
as to attain an approximately equal mean weight in each pen and identified by means 
of wing bands. Birds were inoculated at ten days of age and were observed for 11 
days post-challenge. Necropsy was performed on each bird during which assessment 
of lesions and sampling for mycoplasma culture and serology were performed. 
Bodyweight gains of the different groups were compared. 
Experimental birds 
Species Chicken 
Breed White Leghorn 
Number 360 
Sex 180 male and 180 female 
Weight on Day 1 34 to 45 g 
Health Status Specific-pathogen-free chickens 
(see Appendix for list of pathogens) 
Inclusion/exclusion criteria Only healthy chicks were included in the study 
The chicks were housed in a building which was purpose-built for experimental work 
involving the containment of pathogens and maintenance of Specific-Pathogen-Free 
(SPF) status. Pressure controlled animal rooms with filtered air and controlled 
temperature were used. The rooms were maintained to provide a temperature of 
approximately 30°C at chick level initially, dropping to approximately 25°C after 
approximately two weeks. Temperature and schedules of light were monitored daily 
throughout the study. The feed and water were checked and recorded each morning 
and evening, when the chicks were examined for clinical signs. See Appendix 
for a 
description of the disease containment facilities in the Animal Experimental House. 
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A chick-feed free of antibiotics, coccidiostats and other chemical or biological growth 
promoters was prepared. Chicks were fed ad libitum in feed troughs allowing 
adequate trough space per bird. 
Changes in water intake are sometimes used by field clinicians as an indicator of the 
beginning of a respiratory disease outbreak in commercial flocks. During the trial 
water was provided ad libitum in one bell drinker per cage. Each replicate had its own 
drinker. The water remaining after 12 hours was measured in a1 litre measuring 
cylinder to the nearest 10 ml and the quantity consumed daily by each group was 
calculated for the period from two days before infection until three days after 















Chicken trachea from field outbreak 
2 passages after reisolation from chicken trachea 
-70°C + 3°C 
According to the Standard Operating Procedure 
"Growth of Mycoplasma gallisepticum 
R-PLO" (See Appendix) 
In double sealed containers in ice. 
Approximately 107 cfu total dose in a volume of 
0.25 ml 
0.2 ml per bird intratracheally and 0.05 ml per 
bird into the sinus 
An aliquot of challenge material was returned to 
the laboratory for dose reconciliation 
Non-infected birds were similarly inoculated with sterile mycoplasma broth. Major 
study activities are summarised in the schedule of events below. 
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Schedule of Events 
Age (days) Event 
0 Hatching: sampling of 20 sera from spare chickens for mycoplasma 
serology 
6 Identification of all chicks with wing-tags 
Randomisation of groups and replicates according to weight 
stratification. Allocation of birds to pen replicates 
8 Measurement of water consumption for each replicate. 
9 Measurement of water consumption for each replicate 
10 Intratracheal and intrasinus challenge with Mycoplasma gallisepticum 
Intratracheal and intrasinus challenge with sterile broth of control birds 
11 Measurement of water consumption for each replicate 
12 Measurement of water consumption for each replicate 
13 Individual weighing of chicks 
Individual observation of respiratory signs and measurement of 
water consumption for each replicate 
16 Individual observation of respiratory signs 
20 Individual weighing of chicks 
Individual observation of respiratory signs 
Euthanasia of non-infected birds, observation of lesions, sampling for 
mycoplasma recovery and serology 
21 Euthanasia of infected birds, observation of lesions, sampling for 
mycoplasma recovery and serology 
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Observations and Monitoring 
On the first day of life, serum was collected from 20 spare chicks for Mycoplasma 
gallisepticum antibody analysis. Birds were inspected and weighed at six days of age. 
During the study the mortality per group was recorded daily. Non-infected birds and 
infected surviving birds were killed on days 20 and 21, respectively. Birds were 
examined for lesions of the peritoneum and air sacs and trachea samples were taken 
for mycoplasma recovery. Air sac, peritoneal, pericardial and peri-hepatic lesions 
were scored and recorded. 
Clinical Examinations 
No clinical demeanour scoring techniques were found in the published literature for 
live chickens. Despite attempts to develop such a scoring system for clinical signs, 
with the exception of respiratory signs, it was not possible to identify suitable clinical 
variables for use in assessing clinical demeanour. A `respiratory score' was therefore 
developed. The respiratory signs were recorded and quantified for individual 
chickens as follows (Kempf et al. 1997, Reeve-Johnson et al. 1997a): 
0 no respiratory signs no rales upon auscultation with ear firmly 
applied to thorax of bird, no clinical signs, 
before or during handling. 
1 slight signs mild rales upon auscultation with ear firmly 
applied to thorax of bird, absence of or only 
intermittent signs of snicking or dyspnoea 
only evident upon handling the bird. 
2 moderate signs clear rales upon auscultation may also be 
detected with ear withdrawn a short distance 
from bird, dyspnoea, mild depression or 
snicking evident before handling bird, worsened 
by handling. 
3 severe signs Clear rales upon auscultation, audible with ear 
removed from thorax of bird, clinical signs 
clearly evident in the bird before handling, 
profound and constant dyspnoea, depression, 
possibly accompanied by recumbency and 
' snicking'. 
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Pathological scoring system 
The airsacs of birds were scored at necropsy using a system based on that first 
described by Kleven et al. (1972), and adapted by Kempf et al. (1997) and Reeve- 
Johnson et al. (1997a). 
Lesions of air sacs were scored as follows: 
0 no visible lesions 
1 cloudiness of air sacs 
2 air sac membranes thickened and opaque 
3 consolidated appearance of membranes with large accumulations of 
`caseous' exudate confined to one airsac 
4 as 3 but lesions in 2 or more air sacs 
Lesions of the peritoneum were scored as follows based on the system described by 
Reeve-Johnson et aL (1997a): 
0 no visible lesions 
1 cloudiness of peritoneum 
2 peritoneum thickened and opaque 
3 consolidated appearance of membranes with limited accumulations of caseous 
exudate 
4 as 3 but with large accumulations of `caseous' exudate 
Photographs of representative lesions caused by Mgallisepticum were taken from 
birds which had been infected with Mgallisepticum as part of the preparation for this 
study (Figures 1-5). These were used as an aid to ensure consistency during necropsy 
when scoring lesions. Due to its ubiquitous presence in the litter and in the 
environment in general, E. tali is a major secondary pathogen in complicated 
respiratory disease [CRD] in chickens. To help distinguish pathological changes due 
to M gallisepticum from those due to E. coli a picture showing pathognomonic lesions 
for this organism, which invariably involves signs of inflammatory changes around 
the liver, was also taken from a previously experimentally infected bird for use a 
guide to recognising these (Figure 6). The typical fibrous `tagging' on the 
liver 
surface is termed perihepatitis. 
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Perihepatitis score: 
0 No evidence of inflammatory changes seen on liver surface 
1 Small discrete areas of inflammatory changes on <50% of liver surface 
2 Extensive areas of fibrous `tagging' and inflammatory changes on the 
surface of the liver covering >50% of the liver surface 
Pericarditis score: 
0 No evidence of inflammatory changes observed on the pericardial surface 
1 Small discrete areas of inflammatory changes present on <50% of pericardial 
surface 
2 Extensive evidence of inflammatory changes on >50% of the pericardial 
surface 
Note: 
1 Cloudiness of airsac 
2 No exudate present 
3 No perihepatitis or pericarditis 
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Figure 1: Illustrating airsac lesion score 1 and peritonitis lesion score 0: 
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Note: Right airsac score 0, clear, with some neo- vascularisation, but otherwise 
clear 
Left airsac score 2, thickened airsac, but no exudate present 




Figure 3: Illustrating airsac lesion score 2-3 and peritoneum lesion score 0: 
Note: 
1. This was scored as 2 because the airsac is thickened but not consolidated 
2. Small amounts of exudate are present 
3. No signs of perihepatitis or pericarditis 
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Figure 4: Illustrating lesion airsac lesion score 3 and peritoneum lesion score 0: 
Air sac extended to show thickening and consolidation 
r ý" 
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Note: airsac thickening and exudate present, but peritoneum, pericardium and 
liver 
surface show no signs of gross pathological changes 
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Figure 5: Illustrating airsac lesion score 4 and peritoneum score 0: 
Note: 
.. ý e 
1. Left air sac (extended) showing typical thick 'meaty' appearance with exudate in 
air sac 
2. Right air sac in situ is also severely affected with similar changes 
3. In birds like this one, the abdominal sacs are often also affected 
4. The difference between scores 3 and 4 is determined by the extent of the lesion 
5. No signs of perihepatitis or pericarditis 
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E. coli infected birds: 
















1. Airsac score 4 
2. Pericarditis score 2 
3. Perihepatitis score 2 
4. Lesions such as this, often with accompanying pericarditis are evidence of bacterial invasion 
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Mycoplasma recovery 
Examination of post mortem cultures for Mgallisepticum was performed according to 
the SOP "Recovery of Mycoplasma gallisepticum R-P1O" (see Appendix). 
Mycoplasma serology 
Sera were tested by the slide agglutination test according to SOP "Serological slide 
agglutination tests for Mycoplasma gallisepticum" (see Appendix) 
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Results 
The severity of clinical signs and pathological lesions was clustered according to 
replicate. This was because of the close proximity of birds and environmental 
uniformity for all individuals in the same replicate. Under commercial conditions, 
prevalence of clinical signs is considered on a group basis. 
According to the severity of clinical signs on day 13, pens were ranked according to 
the severity of respiratory signs as indicated by the mean score for each pen. For 
statistical interpretation, the pens were then banded in groups of six, thus giving five 
degrees of freedom for the analysis of correlation data. 
Titre of the inoculum 
The titre of the inoculum was verified as 108 CCU/ml 
Mortalities 
The total number of deaths was 5 out of 360 birds (1.4 percent). 
Two birds (No 366 and 135) died on days 20 and 21 (groups 1& 2). Postmortem 
examination revealed severe lesions of the air sacs, peritoneum and trachea in both 
birds. One bird died on day 16 (No 341) and two other birds from this group (6) died 
on day 20 (No 313 and 193). Only a slight lesion of pneumonia was seen in one of the 
chickens that died on day 20. 
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Clinical examinations 
No clinical signs were observed in non-infected birds. 
The first respiratory signs were observed on Day 13: a few chickens showed dyspnoea 
and sneezing. On the following days, and until the end of the experiment, these signs 
remained frequent. 
The mean respiratory scores for days 13,16 and 20 of the study (i. e. 3,6 and 10 days 
after infection) are given in Table 1. 
Table 1: Mean group respiratory scores (with Standard errors in brackets) for 
six groups each of 60 chickens at 3,6 and 10 day intervals after experimental 
infection with M. gallisepticum. 
GROUP Day 13 Day 16 Day 20 
1 non-infected 0.00 (0) 0.00 (0) 0.00 (0) 
2 0.53 (0.12) 1.05 (0.11) 1.85 (0.14) 
3 0.38 (0.11) 0.47 (0.19) 0.30 (0.12) 
4 0.30 (0.13) 0.47 (0.16) 0.33 (0.11) 
5 0.23 (0.09) 0.50 (0.06) 0.38 (0.19) 
6 0.15 (0.14) 0.65 (0.17) 0.47 (0.15) 
Note: Groups were comprised of six replicated pens of 10 chickens. The six 
uninfected pens of control birds were assigned to group 1. The remaining replicated 
pens were ranked according to the severity of respiratory signs on day 13. Six pens 
were then allocated to each group in order of decreasing severity of signs. Thus the 
six pens with most evidence of respiratory disease to group 2, the next six to group 3, 
until the last six pens contained the inoculated birds showing least evidence of 
respiratory disease and these were allocated to group 6. 
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Water consumption (see Table 2) 
There was a consistent decrease in water consumption after infection in all groups. In 
comparing the mean water consumption data for day 10 (day of inoculation) with day 
11, the decline in consumption ranged from 1.3 percent (Group 3) to 27 percent 
(Group 4). There was a decline in water consumption of 19 percent in the sham- 
inoculated birds between days 10 and 11, thus it was not possible to distinguish 
between the severity of clinical signs based upon water intake alone. Handling the 
birds and the sham-inoculation procedure appeared to affect the water consumption of 
birds as much as the presence of an infecting organism. When the mean group water 
consumption for day 9 (prior to inoculation) and the means of days 11,12 and 13 (the 
three days immediately following inoculation) were compared, there was still a 
notable decrease in water intake. The lowest decrease in water intake was in the 
control (sham-inoculated) birds i. e. 6 percent (Group 1), whilst the depression in 
water intake in groups 2-6 were 10 percent, 12 percent, 19 percent, 9 percent and 7 
percent respectively. 
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Table 2: Daily water consumption (milli-litres) for six groups of 60 birds in 
descending order of disease severity as measured by severity of respiratory signs 
on day 13 (infection with M. gallisepticum occured on day 10 of the study) 
GROUP PEN 
Day 9 Day 10 Day 11 Day 12 Day 13 
1 (Non-infected) a 730 520 470 485 330 
b 700 770 370 650 500 
c 400 410 400 530 320 
d 390 500 460 470 330 
e 440 430 500 600 360 
f 450 640 530 1080 410 
mean 518 545 455 636 375 
Std. Error 141 125 55 208 63 
2 a 530 360 340 370 400 
b 450 400 420 460 490 
c 240 280 440 430 360 
d 520 330 300 380 410 
e 440 350 240 310 460 
f 390 440 360 370 450 
mean 428 360 350 387 428 
Std. Error 97 51 68 121 43 
3 a 530 510 430 460 430 
b 570 510 350 460 500 
c 410 390 310 550 590 
d 400 380 260 320 570 
e 420 350 270 400 400 
f 390 380 270 330 400 
mean 453 420 315 420 482 
Std. Error 70 65 60 80 77 
4 a 690 420 360 520 630 
b 460 390 300 330 380 
c 400 400 320 500 530 
d 440 350 280 410 430 
e 410 440 350 330 360 
f 380 370 250 340 360 
mean 463 395 310 405 448 
Std. Error 105 30 38 79 100 
5 a 490 400 460 470 460 
b 420 380 300 410 420 
c 330 330 270 350 370 
d 470 400 340 440 520 
e 390 440 310 340 340 
f 390 360 320 400 310 
mean 415 385 333 402 403 
Std. Error 53 35 60 46 72 
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6a 430 400 340 410 400 
b 390 290 260 350 360 
c 300 310 240 330 340 
d 390 350 270 380 360 
e 420 400 270 430 420 
f 370 330 310 480 510 
mean 383 347 282 397 398 
Std. Error 42 42 33 50 57 
Bodyweight changes (See Tables 3 and 4) 
The heaviest bird weights on day 20 were recorded in the control group (sham- 
inoculated! uninfected birds). The birds with the most severe signs (group 2), despite 
having had the heaviest mean weight on day 13, were the lightest by day 20 (Table 3). 
There was little difference in bodyweights between groups 3-6. 
The birds in group 2 initially also had a higher rate of bodyweight gain between days 
6-13, attributed to a random affect during allocation. The bodyweight gain for the 
post-infection phase of group 2 (days 13-20) is markedly lower than any of the other 
groups and they also have the lowest gain over the whole trial period (Table 4). There 
was little difference in bodyweight gain for birds with milder signs (groups 3-6), 
however all had a lower gain than the control group of birds. (Table 3). 
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Table 3: Mean bodyweights (grams) of six groups of 60 birds, four days before 
experimental inoculation with M. gallisepticum and three and ten days after 
inoculation (standard error in brackets) 
GROUP Day 6 Day 13 
1 (non-infected) 56.20 (0.2) 115.90 (2.4) 
2 56.15 (0.1) 120.90 (3.0) 
3 56.10 (0.1) 113.25 (1.4) 
4 56.15 (0.4) 114.00 (2.2) 
5 55.90 (0.1) 113.50 (1.1) 
6 56.10 (0.2) 112.00 (1.3) 








Table 4: Mean body weight gains (grams) of six groups of 60 chickens 
experimentally inoculated with M. gallisepticum over three time periods. 
Inoculation was on Day 10 
TIME INTERVAL 
GROUP DAY 6-13 DAY 6-20 DAY 13-20 
1 (non-infected) 59.70a 
2 64.80' 
3 57.20a 
4 57. ä5a 
5 57.60a 
6 56.00a 
152. lOa 92.40a 





N. B. Each group consisted of six replicated pens of 10 chickens 
Superscripts denote significant differences down the columns for each time interval (p< 0.05) 
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Post mortem examinations (see Table 4) 
Summarised and rank data are presented in Tables 8 and 9 and mean lesion scores for 
each group are presented in Table 5, respectively. There was a clear correlation 
between the presence of airsac and peritonitis lesions, this is illustrated by Figure 7, 
and tested to be significant Table 10. 
No airsac or peritonitis lesions were observed in control (non-infected/ sham- 
inoculated) chickens. Statistical analysis indicated that birds from all infected groups 
had significantly (p=0.05) more severe airsac lesions and peritonitis lesions than 
control birds. 
Table 5: Mean airsac and peritonitis scores for six groups of 60 chickens 
grouped according to the severity of respiratory signs three days after 
experimental infection with M. gallisepticum. Necropsy was performed on all 
birds ten days after infection (standard errors are given in brackets) 
GROUP Airsacs Peritonitis 
1 (non-infected) 0.00 (0) 0.00 (0) 
2 1.63 (0.5) 1.28 (0.6) 
3 1.55 (0.6) 0.62 (0.3) 
4 0.52 (0.3) 0.27 (0.3) 
5 0.23 (0.1) 0.05 (0.1) 
6 0.15 (0.1) 0.07 (0.1) 
N. B. Each group consisted of six replicated pens of 10 chickens 
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Figure 7: The relationship between ranked data (by pen) for peritonitis and 
airsac scores for the 30 pens of 10 chickens which were infected with 
M. gallisepticum 
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N. B. Numbers next to plotted points indicate the number of identical values 
Mycoplasma recovery (Table 6) 
No mycoplasma were recovered from non-infected birds. Mycoplasma were 
recovered from 70 of the 300 birds (23.3 percent) in the experimentally infected 
groups. 
Table 6: Number of positive Mycoplasma gallisepticum samples / number of 
tested samples from six groups of 60 experimentally-infected chickens 
GROUP TO T-1 T-2 
1 (non-infected) 0/60* 0/60 0/60 
2 60/60 60/60 60/60 
3 8/60 18/60 40/60 
4 2/60 6/60 15/60 
5 0/60 0/60 1/60 
6 0/60 0/60 0/60 
N. B. Each group consisted of six replicated pens of 10 chickens 
T-1 and T-2 were ten fold dilutions from the TO seeder tube (see Appendix). The serial 
dilution increased the sensitivity of the test 
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Mycoplasma serology 
In the 20 chickens blood sampled on Day 0, no maternal antibodies to 
Mgallisepticum were found. The number and percentage of seropositive birds ten 
days after infection is given in Table 7. 
Table 7: Seroprevalence of M. gallisepticum ten days after experimental infection 
(day 20) 
GROUP 
1 (non-infected) 0/60 0% 
2 46/58 79% 
3 24/60 40% 
4 4/60 7% 
5 0/60 0% 
6 0/57 0% 
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Overview of results 
Five birds died during the course of the study, there was no particular group 
disposition and these were considered within the normal bounds of `incidental' 
mortalities expected within a group of this size (i. e. <1.5%). A few days after 
infection, birds showed respiratory signs and the intensity increased until last 
observation day. The mean bodyweight and the mean water consumption of infected 
birds was decreased compared to non-infected ones, however a decrease in water 
intake was also noted after sham-inoculation. This is presumably due to the stress to 
the birds of being handled and the inoculation procedure. A similar level of stress 
would be caused by parenteral vaccination. Lesions of air sacs and peritoneum were 
observed in 67 percent and 58 percent, respectively, of 300 Mgallisepticum 
inoculated chickens. Mgallisepticum could be reisolated from 100 percent of birds in 
the most severely affected group of 6 pens (mean airsac score 1.63, mean peritonitis 
score 1.28). According to serum agglutination tests, 79.3 percent of birds were 
positive in the most severely affected 6 pen group (mean score 1.63 for airsacs and 
1.28 for peritonitis); 24/60 were positive for birds from the second most severely 
affected band of 6 pens (mean airsac score 1.55; peritonitis score 0.62); for the fourth 
group only 4/60 were seropositive (airsac score 0.52; peritonitis score 0.27). No 
seropositivity to Mycoplasma gallisepticum was detected for the remaining two 
groups of 6 pens each with lower mean scores (airsac scores 0.23 and 0.15 and 
peritonitis scores of 0.05 and 0.07). This may indicate a failure of 
infection at 
inoculation. 




Percent mycoplasma reisolation 
Percent mycoplasma seropositive 
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Six pens were allocated to each group, with ten chickens in each pen. The pen has 
been taken as the statistical unit, and so where possible the scores used in the 
correlation analysis were the pen means, i. e. 36 mean values were used. However, 
percent mycoplasma reisolation and seroprevalence were only recorded for each 
group, and so these parameters have been correlated with the group means of the other 
three variables. 
The results presented consist of correlation coefficients and p-values for each pair of 
variables. In each case, Spearman's correlation coefficient was calculated, i. e. given n 
pairs of observations (x; , y; ) (i=1,2,..., n) 
for two variables x and y the coefficient is: 
e= 





where r; denotes the rank of x;, s; denotes the rank of y;, and r ands denote the mean 
values of the ranks of x and y respectively. The p-value was obtained by calculating 
the probability of obtaining a correlation at least as big as the one observed for the 
given number of observations, under the hypothesis of there being no relationship 
between the two variables. This was done automatically using the CORR procedure 
in the SAS for Windows (Version 6.12) package. 
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Table 8: Clinical and pathological data and ranked data (by pen replicates) for 
chickens experimentally inoculated with Mycoplasma gallisepticum. 








































































































































































































































Table 9: Clinical and pathological data and ranked data (by severity banded 
groups) for chickens experimentally inoculated with Mycoplasma gallisepticum 
Chicken group data RANKS RANKS RANKS RANKS RANKS 
Airsac Resp. Peritonitis Mg Mg Airsac Resp. Peritonitis mg mg 
score score score Reisoln Sero- score score score Reisoln Sero- 
(%) positive positive 
(%) 
0.00 0.00 0.00 0.00 0.00 1 1 1 1.5 2 
1.63 1.83 1.28 100.00 79.31 6 6 6 6 6 
1.55 0.30 0.62 66.67 40.00 5 2 5 5 5 
0.52 0.33 0.27 25.00 6.67 4 3 4 4 4 
0.23 0.38 0.05 1.67 0.00 3 4 2 3 2 
0.15 0.48 0.07 0.00 0.00 2 5 3 1.5 2 
In Table 10, correlations significant at the 5 percent level have been highlighted in 
bold. For the pen data all the correlations between airsac score, respiratory score and 
peritonitis score were significant, although the correlations involving respiratory score 
were not very strong. For the grouped data, all the correlations were significant 
except those involving respiratory score. However, the small number of observations 
should be taken into account when considering the size of the correlation coefficients. 
Table 10: Correlation of clinical and pathological scores in chickens 











Pen data Respiratory score 0.48 (0.003) - - - 
(n=36) Peritonitis score 0.82 (<0.001) 0.48 (0.003) - - 
Grouped % Mycoplasma reisolation 0.99 (<0.001) 0.32 (0.54) 0.90 (0.01) - 
data 
(n=6) % Mycoplasma seropositive 0.94 (0.005) 0.27 (0.60) 0.94 (0.005) 0.95 (0.003) 
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Discussion and conclusions 
It was concluded that water consumption is not a parameter that can be used to 
quantatively grade the severity of disease. However, it can be of use to detect the 
presence of a number of physiological stressors upon the birds which may include 
disease. A decrease in water usage is one of the parameters used by commercial 
chicken producers to detect the outbreak of disease and is used by many production 
units as a trigger to commence preventive or metaphylactic medication programmes 
(Lister, S., 1996 - personnal communication). Based upon these data, although water 
consumption may be indicative of disease or another episode of stress (such as that 
induced by handling and sham-inoculation or vaccination), it does not appear to be 
useful as an indicator of disease severity. 
Growth was adversely affected by infection with Mycoplasma gallisepticum, for birds 
with the most severe clinical signs, bodyweight at the end of the 10 day study period 
was decreased by 11 percent. According to Kempf, I. (1998 -personal 
communication) the economic losses due to Mgallisepticum infection to producers 
over the whole grow-out period can be up to 20-30 percent reduction of weight gain, 
10-20 percent decrease in feed conversion efficiency, 5-10 percent mortality and 10- 
20 percent condemnation of carcasses at processing. There was no significant 
difference (p=0.05) between the final bodyweights of groups which exhibited milder 
clinical signs. The mean bodyweight of groups 3-6 at the end of the study period was 
4 percent below that of the sham-inoculated control birds (Table 3). Bodyweight 
would therefore seem to be of limited value as an indicator of disease severity, and 
only useful as a distinguishing criterion between severe and or very mild disease, but 
did not show a gradation in response. This could be related to the fact that until the 
physiological reserve of the respiratory system is compromised, there is little effect 
upon growth performance. The bodyweight gain data supports these findings 
(table 
4), birds with severe clinical syptoms (group 2) showed bodyweight gains 28 percent 
lower than control birds (group 1) over the post-infection period (days 13-20), whilst 
there was no significant difference (p=0.05) between the mildly infected groups (3-6) 
and bodyweight gain was only 6 percent below the control birds. This study was only 
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conducted over a 10 day period after infection and greater depression in bodyweight 
gains may become evident with more chronic disease. However, early indicators of 
disease are of more use to the commercial producer in order to instigate treatment 
before major economic losses occur. 
Airsac lesions were closely correlated with clinical signs. However, as illustrated in 
Figure 8, before clinical signs becoming evident airsac lesions generally surpass a 
threshold of approximately 1.6. This too supports the hypothesis that there is a 
physiological reserve in the respiratory system which can be compromised before 
overt clinical signs are recorded. Peritonitis and airsac scores closely followed each 
other (Tables 5,8 and 9), these parameters are strongly correlated with each other and 
with the clinical respiratory score (Table 10) indicating that they are good indicators 
of disease severity (Reeve-Johnson 1997). Although no other literature investigates 
the correlation between clinical signs and airsac or peritonitis lesion scores, the lesion 
scoring system, upon which the system used in this research is closely based, has been 
widely used since it was first described by Kleven et al. (1972). Recent examples 
include (Kempf et al. 1997, Reeve-Johnson et al. 1997a, Charleston et al. 1998). 
However, it can be seen from Table 5 that at low airsac and peritonitis lesion scores, 
the standard error approaches the mean, indicating the increased variability at low 
mean group levels when a few birds may have lesions and others none. This indicates 
that at low lesion scores, the scoring systems have less predictive value for the status 
of other birds in the group. At mean airsac lesion scores 1.63 and 1.55 the mean 
group levels were approximately three times the standard error (likewise for 
peritonitis score 1.28), at airsac lesion score 0.52 and peritonitis score 0.62, the 
standard error was approximately half the mean and at airsac lesion score 0.15 and 
peritonitis score 0.05 and 0.07 the standard errors was approxiamtely equal to the 
mean. Mycoplasma reisolations and seropositivity increased with worsening 
respiratory signs. 
The statistical models are based upon linear correlations and this can be misleading 
because the clinical scoring systems do not give a linear representation of pathological 
progression. Although clinical scoring systems are designed to reflect a gradation 
in 
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disease severity and progression, they have to be based upon signs which are 
distinguishable by the observer. The progression from not presenting a clinical sign 
to it becoming present may reflect either a small or alternatively a very large 
pathological progression. Consequently it is important when discussing clinical signs 
not to regard a doubling in the score (which is an arbitary gradation of clinical signs) 
as a doubling in pathological disease severity. 
Table 10 shows the strong overall correlation between the indicators of disease 
severity investigated in this study, while Figure 8 is useful in illustrating that the 
relationship between the variables, whilst positively correlated, is not linear. 
Figure 8: A graphical representation of the relationship between airsac score, 
peritonitis score, respiratory score, seroprevalence and microbiological 
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Chapter 4: Experimental infection of pigs and the evaluation of 
disease severity 
Introduction 
In 1995 in Europe, there were 110.9 million pigs which accounted for 742 million 
ECU of animal health sales which was 23 percent of the total European animal health 
market. Forty-one percent of these animal health sales were antibacterial products 
(Anon 1997). Respiratory disease, involving Actinobacillus pleuropneumoniae is a 
cause of severe loss to the pig-rearing industry world-wide (Nicolet 1992). The 
disease is characterised by a haemorragic necrotising pneumonia and fibrinous 
pleuritis. Twelve serotypes of A. pleuropneumoniae have been described. The 
distribution of serotypes varies widely by geographic region. 
A. pleuropneumoniae is a gram negative capsulated rod. Based on Nicotinamide- 
Adenosine-Dinucleotide (NAD) requirements, A. pleuropneumoniae can be divided 
into NAD-dependent (biotype 1) and NAD-independent (biotype 2) strains. Biotype 2 
strains were formerly called Pasteurella haemolytica - like organisms, but in 1983, 
these strains were transferred to the genus Actinobacillus and combined with 
Haemophilus pleuropneumoniae into the new species A. pleuropneumoniae (Pohl et 
al. 1983, Niven and Levesque 1988). At present, 10 serotypes have been described in 
biotype 1 (serotype 5 is divided into a& b) (Neilsen 1986). Two serotypes have been 
described in biotype 2 (Fodor et al. 1989). 
Although all serotypes cause disease, their virulence varies. Field observations and 
experimental infections provide evidence that biotype 2 strains are less virulent than 
biotype 1 strains, and it has been reported that, based on field observations, biotype 1 
serotypes 1,5a, 5b, 9 and 10 strains are more virulent than other biotype 
1 serotypes 
(Dom and Haesebrouck 1992). This has not been confirmed under experimental 
conditions and the high pathogenicity of A. pleuropneumonia is considered to 
be due 
to a number of factors (Nicolet 1992). 
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It is generally accepted that the infective organism is inhaled directly into the lungs, 
however, using intravenous inoculation of a biotype 1 serotype 2 strain, the typical 
necrotising fibrinous pleuritis has been reproduced (Haesebrouck, F., 1998 - personal 
communication). 
Actinobaccillosis is a major respiratory disease in the pig-rearing industry. The most 
important virulence factors of A. pleuropneumoniae are the Apx-toxins that lyse 
alveolar macrophages and polymorphonuclear cells (Kamp and van Leengoed 1989, 
Cruijsen et al. 1992). Thus A. pleuropneumoniae escapes from the primary defence of 
the host. 
Three experimental infection models were used, each involving a different strain of A. 
pleuropneumoniae. A clinical scoring system was devised in order that a correlation 
between the clinical picture and pathology could be investigated for this variable 
condition. The same clinical scoring systems and pathological criteria were used in 
each study. 
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Materials and Methods 
Landrace x Large White x Duroc pigs of minimal disease status were used. Animals 
were held under a natural day and night lighting regime in thermostatically regulated 
rooms maintained at 21± 2°C. The pigs were moved from the breeding herd to the 
animal facilities and housed in Multi Purpose Boxes (MPBs). These MPBs allow 
strict barrier conditions to be maintained between groups of animals by means of 
airtight rooms with a High Efficiency Particulate Air (HEPA) filtration system, 
negative pressure, airlocks where attendants change clothes and boots, and a vacuum 
circuit for manure removal to autoclaves. Rubber mats were placed on the concrete 
floor to provide a lying area. Each MPB was split into two separate pens. Pigs were 
identified by an ear-tag. 
Before entering a MPB, workers changed overalls, boots, surgical masks, hats, and 
gloves. Before the studies, MPBs were cleaned and disinfected with formaldehyde. 
During the studies, boxes were cleaned daily with high pressure water. Directly 
after cleaning, the floor was wiped dry so that the pigs were not able to drink this 
water. 
The health status of the animals was checked upon arrival. Health was judged on 
the basis of demeanour and absence of disease signs in particular of a respiratory, 
nervous and locomotory nature. Only healthy animals were used. Pigs were 
observed closely during the acclimatisation period to ensure adequate feed and 
water intake and for evidence of fighting, vices or incidental diseases. Pigs were 
observed at least twice daily throughout the study. 
Drinking water fit for human consumption from the local drinking water company 
was available ad libitum. Water utilisation was measured with a water meter and 
spilled water was collected in catchment bowls beneath the floor slats. 
Water 
consumption was calculated by subtracting the spilled volume of water 
from the total 
utilisation for each group of pigs. The water intake of groups of pigs was monitored 
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in each study to determine whether this could be used as an indicator of disease 
outbreak or a measure of disease severity. 
A single batch of irradiated feed of standard formulation was used. This feed was 
prepared under Good Manufacturing Practice standards (GMP) and did not contain 
any antibiotics. The quantity of feed offered and quantity of remaining feed at the end 
of the study were recorded. Feed was provided daily during the morning at a rate of 
approximately 65 g feed per kg bodyweight. 
Pigs were weighed using an electronic weighing system at intake, on the day before 
challenge and on the day of necropsy. The pre-intake weights were used to allocate 
animals to groups. Male and female pigs were separately ranked in order of weight 
and then randomly allocated to each group in sequence such that an even sex balance 
and approximately equal weight of pigs were obtained in each group. 
Pigs were experimentally infected with A. pleuropneumoniae once they had 
acclimatised. In Study 1 and Study 2, pigs were infected with aerosolised A. 
pleuropneumoniae serotype 3 and 5a respectively. In Study 3, an endobronchial 
infection method was used to deliver serotype 9 to the level of the tracheal bifurcation 
in the lungs. 
Clinical examinations 
Pigs were examined for clinical signs after challenge infection twice daily 
for 
approximately ten days. Pigs were examined for welfare purposes more 
frequently as 
required. Pigs showing signs of moderate distress likely to progress or continue were 
euthanased and post mortem examinations performed. Moderate 
distress was defined 
as a clinical demeanour score of 3 on two consecutive examinations 
12 hours apart or 
a single clinical demeanour score of 4. 
Rectal temperatures were determined with an electronic thermometer in the morning 
for the two days preceding challenge in order that the pigs became habituated to the 
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practice. On the following days, temperatures were determined in the morning and in 
the afternoon. 
Scoring of clinical signs and pathological lesions caused by experimental 
Actinobacillus pleuropneumoniae infections in pigs 
Emphasis was placed upon attempting to define a suitable scoring system for use in 
these three studies. Systems ranking clinical signs as ̀ mild', `moderate' and `severe', 
were felt to be too loose. Although experienced clinicians who regularly used such 
systems felt that they were reliable and a good reflection of clinical demeanour in 
their own hands, there was not enough information which could be transferred 
consistently to other individuals. Information transfer is a major objective of a 
scoring system and to maximise this a more detailed system was devised. Difficulty 
was also experienced with systems which were too detailed. Different diseases may 
exhibit the same signs but different signs may also be presented by the same disease. 
Likewise individual animals vary greatly in the disease signs that they present and the 
order in which they are presented during the course of a disease episode. The result 




1 (first signs of disease) 
2 (clearly discernible 
disease signs) 
3 (very dull) 
4 (severely diseased) 
Alert pig that responds to an observer entering 
the pen, carries out normal behaviour and 
evades handling 
Less active and alert than normal pig, exhibits 
first signs of disease, may cough, skin may be 
blotchy, but still evades handling 
Pig slow in evading handling, walks about two 
metres, does not exhibit many normal 
behaviour activities, it may lie down while 
observer is in the pen 
Pig losing interest in the environment, may 
require stimulation to move, prefers to lie, may 
not stand for more than one or two minutes 
Totally disinterested in the environment and 
no effort to move away from observer even 
upon stimulation, difficulty in standing, 
requires immediate euthanasia 
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Respiratory score 
It is very difficult to observe respiratory movements in a healthy pig, it is also not 
possible to auscultate a pig easily with a stethoscope without handling. The stress 
associated with restraining and handling pigs generally causes a large increase in 
respiratory rate. A scoring system was therefore designed to describe the increasing 
respiratory effort of a pneumonic pig, which can be performed by careful observation 
from a distance. 
Respiratory score 
0 Normal, no obvious respiratory movements, even when pig 
moving about pen 
1 Respiratory rate slightly increased - have to watch pig carefully 
to notice, when recumbent. Respiratory movements clearly 
evident when pig moving about pen 
2 Respiratory rate obviously increased, respiratory movements 
evident when pig recumbent. Abdominal respiratory 
movements clearly evident when pig moving about pen 
3 Respiratory rate rapid at rest with pronounced abdominal 
respiratory phase. Dyspnoea immediately evident if pig forced 
to move in pen 
In one study (PNE9501) a cough score was also used: 
0 No coughing within five minutes of observation or when 
observer enters pen and makes pig move 
1 Coughing only when pig made to move 
2 Pig coughs once or twice during 5 minute observation and 
becomes worse once pig made to move 
3 Frequent coughing in resting pig 
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Post mortem examinations 
Pigs were euthanased with sodium pentobarbital (15 mg/kg) intravenously and 
exsanguinated by section of the carotid artery. Abdomen and thorax were opened and 
examined. Heart, liver, spleen, kidney were grossly examined and abnormalities were 
recorded. Lungs and trachea were taken out of the thorax, heart, larynx and all parts 
not belonging to the respiratory tract were trimmed off and then the lungs were 
weighed. Each lobe was examined visually and by palpation. The percentage of lung 
affected was estimated and recorded and the sites of pleuritis and lung lesions were 
recorded on a lung map. The lung lesions were cut with a knife and the tissue was 
swabbed with a cotton swab for bacteriological examination. Swab samples were 
taken from lesions of pneumonia (1 per pig) and from affected joints or periarticular 
tissues (1 per pig) for bacteriology. When no lung lesions were present, samples for 
bacteriology were taken from the middle of the lung lobes. The nature of the lung 
lesions based on clearly visible gross changes were recorded as: 
catarrhal: grey-red discoloration of the consolidated parenchyma 
haemorrhagic: -parenchymal haemorrhages 
necrotic: tissue necrosis 
fibrinous: fibrinous dilatation of interlobular septae, dry, red appearance of 
the cut surface 
abscess: abscess surrounded by a fibrous capsule 
fibrosis: connective tissue formation 
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Figure 1: Typical Actinobacillus pleuropneumoniae infected lungs sampled at 
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Note the fibrous adhesions on the pleural surface and with consolidation and congestion of the right 
lobe. The caudo-dorsal distribution of lung lesions of this example is typical of Actinobacillus 
pleuropneumoniae infection as opposed to the cranio-ventral distribution of lesions more typical of 
Mycoplasma spp. infections. 
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In one study (PNE9501), hyperplastic changes in the thoracic, sternal and tracheo- 
bronchial lymph nodes were recorded. The lymph nodes were examined and 
enlargement was recorded as: 
Lymph node score 
0 normal size 
1 mildly enlarged (enlarged by less than 1/3) 
2 moderately enlarged (enlarged by 1/3 or more, but less than 
double) 
3 severely enlarged (enlarged by twice or more the normal size) 
Bacteriology 
The samples of nostrils, tonsils and lung tissues collected at necropsy were cultured 
on Columbia agar supplemented with 5% blood with a Staphylococcus intermedius 
inoculation streak. Identification of the colonies as A. pleuropneumoniae was based 
on the satellitism phenomenon, the positive haemolysis and the positive CAMP 
reaction. 
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Study 1 PUK9501: 
Overview 
Five groups, each of 12 pigs, 16-27 kg bodyweight were challenged with 
Actinobacillus pleuropneumoniae (serotype 3) by intranasal spray, 9x 10' cfu per 
pig. Each group of 12 pigs was kept in the same room, but split into two identical 
replicated pens of 6 pigs each. All pigs in- a single group were sequentially infected 
before pigs in the next group were inoculated. Because of the intimate contact of pigs 
with others in the group and the natural route of infection of A. pleuropneumoniae is 
by aerosol and direct contact, the statistical unit could be considered to be the group in 
a single airspace (i. e. 12 pigs). In the results section for the purposes of correlating 
the clinical data with pathological data, individual pig data was used, while for 
measurements of water consumption and feed intakes because pigs were kept in 
groups, group data had to be used. Pigs were monitored for clinical signs, raised body 
temperature, bodyweight changes and food intake for 14 days after experimental 
infection. Clinical scores were calculated from the observations of demeanour and 
respiratory abnormalities. Prior to challenge infection, rectal temperatures ranged 
from 38.7°C to 40.5°C. High values in apparently normal pigs are commonly 
recorded and are assumed to be a response to handling. Animals were considered 
febrile if the rectal temperatures were more than 2 standard deviations above the mean 
for normal pigs (all records, Days 8-10,39.5 ± 0.42°C ), i. e. > 40.3°C. Surviving pigs 
were euthanased for post mortem examination 14-15 days after challenge and 
examined for lesions of pneumonia and presence of the challenge organism. The 
terminal clinical scores and body temperatures in addition to the bodyweight and 
growth parameters were then tested for statistical correlation with each other, and with 
the gross pathological signs of disease recorded post mortem. These parameters were 
plotted on graphs to illustrate the relationships between the variables. 
The major 
events in the study are summmarised in the following `schedule of events'. 
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Challenge inoculum: 
Organism Actinobacillus pleuropneumoniae 
Strain and serotype K669, Serotype 3 
Source Pneumonic pig lung, isolated at MAFF 
Veterinary Investigation centre Bury St Edmunds, 
Suffolk, UK. February 1994 
Pass number Low passage (< 6 passages) 
Storage details Ultracold deep freeze (-78°C approximately) 
Culture details Broth culture 
Challenge dose 9x 105 colony-forming units (cfu) per pig 
Dose reconciliation Dose reconciliation by volume was performed 
Dose volume 3 ml per pig 
Administration Intranasal spray application, approximately equal 
quantities in each nostril 
Schedule of events: 
Day 1 Introduce 60 Specific Pathogen Free Pigs 
Commence feeding antibiotic-free feed and maintain feed 
intake records. 
Days 1-5 Allow pigs to acclimatize 
Day 6 Commence twice daily records of water intake 
Day 8 Take rectal temperatures once 
Day 9 Take rectal temperatures once, weigh pigs 
Day 10 Challenge pigs (afternoon) 
Take rectal temperature once 
Day 11 Commence frequent clinical observations. Commence twice 
daily rectal temperatures. Emergency post mortem 
examinations if necessary (to end of study) 
Day 12 Weigh pigs 
Day 14 Cease records of water intake 
Day 16 Weigh pigs 
Day 17 Last rectal temperature 
Day 18 Start single daily clinical examinations 
Day 23 Weigh pigs 
Day 24 Last clinical examination 
Weigh and necropsy half surviving pigs in each group 
Day 25 Weigh and necropsy all remaining pigs 
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Results 
Challenge infection produced moderately severe disease. Clinical signs including 
increased clinical demeanour and respiratory scores, sneezing and coughing were seen 
commencing 17 hours after challenge. All pigs became ill, with pronounced illness in 
seven animals and clinical signs persisting for 14 days in eight animals. Two pigs 
were euthanased within 30 hours of infection, lung lesions extended to 33 percent and 
53 percent of the lung area. One was euthanased for humane reasons nine days after 
challenge. Marked pneumonia, affecting 23 percent of lung area, was observed in this 
pig at post mortem examination. The remaining pigs survived to the end of the study 
period and modest lesions of pneumonia affecting from 1-5 percent of lung area was 
observed. The clinical observations are summarized in Tables 1 and 2. 
Intake of water 
Water intakes on Day 11 for the period commencing approximately 30 hours after 
infection were reduced by approximately 40 percent in comparison to the previous 24 
hours. Water intakes recovered after Day 11. The post-infection water intake in 
group 4 was half that of the other groups, group 4 was the median group in terms of 
both clinical scores and percentage lung consolidation upon pathological 
investigation. There was no significant difference between the water intakes of the 
other groups of pigs. The depression in water intake does not appear to 
have any 
direct relationship with overt clinical signs or gross pathology observed upon 
necropsy. 
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Table 1: Summary of clinical observations of five groups of 12 pigs 
experimentally infected with A. pleropneumoniae serotype 3 
Group Number and percentage of pigs (ex. 12) showing: 
Intermittent Prolonged Mortality No 
disease signs disease signs significant 
illness 
1 10 (83%) 8 (66%) 0 (0) 2 (17%) 
2 9 (75%) 6 (50%) 1 (8%) 0 (0) 
3 7 (58%) 2 (17%) 1 (8%) 1 (8%) 
4 9 (75%) 6 (50%) 0 (0) 1 (8%) 
5 11 (92%) 7 (58%) 1 (8%) 0 (0) 
Intermittent disease signs: demeanour score of at least 2 on at least one 
occassion 
Prolonged diseased signs: demeanour score of 2 on at least 4 days 
in any period 
of 7 days; excludes pigs that required euthanasia 
Mortality: pig required euthanasia prior to end of the study 
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Table 2: Summary of clinical scores for five groups of 12 pigs experimentally 
infected with A. pleuropneumoniae serotype 3 
Clinical scores 
[means and Standard Error ; median values in brackets] 
Total study period* 
Group Demeanour Respiratory 
signs 
1 16.6 ± 9.1 20.8 ± 12.7 
(18.5) (23.0) 
2 12.4±5.9 19.0±8.2 
(14.0) (17.0) 
3 10.4 + 6.4 14.0 ± 9.0 
(11.0) (14.0) 
4 13.5 ± 7.9 17.6 ± 9.5 
(13.5) (19.0) 
5 11.6±6.3 14.8±5.3 
(13.0) (15.0) 
N. B. n=12 pigs per group. 
* Mean of total scores for pigs in each group recorded daily for 14 days post- 
challenge 
Rectal temperatures 
Mean rectal temperatures rose to a peak on the afternoon of Day 11 (24 hours after 
experimental infection) with the majority of pigs in all groups being febrile. 
Temperatures fell rapidly after Day 11. The pattern of the temperature responses was 
not significantly different in any group (Kruskal-Wallis test: p>0.05). 
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Bodyweight changes 
Mean group bodyweight is displayed in Table 3. Bodyweight values for pigs that 
required euthanasia before the end of the study were excluded from summary data. 
The large standard errors quoted in Tables 2 and 3 for daily liveweight gain after 
infection, illustrated the differing impact that disease had on individual pigs. Despite 
having pigs of a similar age, weight and genetic background, infected with the same 
pathogen under the same experimental conditions, in some pigs there was a far greater 
negative impact on growth than in others. Although there were no pre-experiment 
liveweight gain data available, the pigs were approximately the same age and weight 
at the start of the study. This can be taken as evidence of similar individual 
liveweight gains prior to the study. The standard error of mean daily liveweight gain 
for the period Day 9-12 was greater for each group than the standard deviation over 
the whole period of Day 9-23. This illustrates that the acute phase of disease had a 
greater impact on growth uniformity than the later more chronic phase. In the inital 
phase of disease, some pigs exhibited weight loss, while others continued growing at 
approximately their pre-infection growth rate. This was at least partly due to the 
observed inappetance of some pigs and apparently normal appetites of others during 
this phase. From Day 12 after infection, all pigs were were growing again. 
The bodyweight changes between Days 9 and 12 represent the acute loss in weight or 
growth check associated with inappetance (Table 3). Daily liveweight gains from Day 
9 to Day 12 were lowest in Group 2 (Mean 0.06 ± 0.62 kg/day, median 0.17) and 
highest in Group 3 (mean 0.41 + 0.40 kg/day, median 0.50). Differences between 
groups were not statistically significant (Kruskal-Wallis test, p=0.65). 
The bodyweight changes between Days 9 and 23 represent the effect of the induced 
disease on growth rate. The performances of the different groups were different, 
ranging from a mean of 0.84 ± 0.07 kg/day (median 0.82) for Group 3 to a mean of 
0.66 ± 0.08 kg/day (median 0.64) for Group 5. Data were not normally distributed 
and non-parametric tests were performed. The overall distribution of results was 
significantly different from random distribution (Kruskal-Wallis test, p=0.008). 
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Four group to group comparisons were significantly different: Group 1 to 3 (p < 
0.05), Group 2 to 5 (p < 0.02), Group 3 to 4 (p < 0.05) and 3 to 5 (p < 0.001), using 
Mann-Whitney tests. 
Table 3: Summary of bodyweight changes and food conversion ratios for five 
groups of 12 pigs experimentally infected with A. pleuropneumoniae Serotype 3 
Group Daily liveweight gain (kg/day) 
[Means and Standard Errors, medians in brackets] 






0.10 ± 0.80 
(0.25) 
0.06 ± 0.62 
(0.17) 
0.41 ± 0.40 
(0.50) 
0.36 ± 0.59 
(0.33) 
0.14 ± 0.63 
(0.33) 
0.67 ± 0.23 
(0.73) 
0.81 E 0.15 
(0.82) 
0.84 ± 0.07 
(0.82) 
0.72 ± 0.24 
(0.70) 











Feed intake and food conversion ratios 
The food conversion ratios (FCRs) are presented in Table 3. 
Necropsy findings 
Individual lung maps were used to record gross pathological changes. 
Marked multiple lesions of acute pleuropneumonia with extensive lung oedema were 
observed in pigs euthanased within 30 hours of challenge infection (Pig Nos. 13 and 
32). The lesions extended to 53 percent and 33 percent of the lung area, respectively. 
Lung-to-bodyweight ratios were high (in percentage terms: 2.9% and 1.82% 
respectively, normal < 1.06%) reflecting the extent of the lesions. Pig 57 was 
euthanased 9 days after challenge and had 23 percent of lung area affected with 
scattered foci of pleuropneumonia showing some chronic changes, with fibrosis, 
adhesion and necrotic centres. The lung-to-bodyweight ratio was 1.31 percent. 
Marked lesions of tenosynovitis with surrounding oedema affecting the elbows and 
hocks were observed. 
A variety of pneumonic lesions were observed during post mortem examination of the 
lungs of the pigs that survived to the end of the study. Lesions were of chronic 
pleuropneumonia with fibrosis, caseous necrotic centres and pleuritic adhesions which 
affected up to 55 percent of lung area. There was marked variation 
in the area of 
lungs affected in all groups, many pigs having little or no pneumonia 
involvement. 
Seven pigs in Group 5, had lesions comprising greater than 1 percent of 
lung area, but 
only one pig had >5 percent of lung area affected. Four, 
five, two and four pigs had 
more than 5 percent of lung involvement in Groups 1-4, respectively 
(Table 4). 
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Table 4: Summary of distribution of lesions over the total lung area at necropsy, 
14 to 15 days after experimental infection with A. pleuropneumoniae serotype 3, 
for 58 pigs 
Group Number of pigs with percent pneumonia in range: 
0-1% 1.1-5% 5.1-15% >15% 
1 6 2 0 4 
2 2 4 3 2* 
3 6 3 2 0* 
4 6 2 2 2 
5 4 6 1 1 
N. B. n= 12 pigs per group. 
*Pigs requiring euthanasia within 30 hours of chal lenge infection (one in each 
of Groups 2 and 3) excluded from analysis 
The percent pneumonia calculated for each pig, including those that required 
euthanasia prior to the end of the study, were analysed statistically. The data were not 
normally distributed (hence the large range) so non-parametric tests were performed. 
The distribution of the data were not significantly different from random distribution 
(Kruskal-Wallis test, p=0.54) 
Median lung-to-bodyweight ratios reflected the values for percent pneumonia; mean 
values were distorted by individual pigs with high values in Groups 1-3 (Table 5). 
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Table 5: Summary of necropsy results for 60 pigs experimentally infected with 
Actinobacillus pleuropneumoniae serotype 3 
Group Lung lesion measurements 





11.1 ± 17.0 
(1.3) 
11.9 ± 16.3 
(4.6) 
4.6 + 9.2 
(1.6) 
4 10.0 ± 17.6 
(1.2) 





1.20 ± 0.44 
(1.06) 
1.27 ± 0.54 
(1.13) 












**Number of pigs positive for A. pleuropneumoniae in lung tissue (12 pigs per 
group) 
Bacteriology 
A. pleuropneumoniae was recovered from the lungs of the majority of pigs with >7 
percent pneumonia involvement. The number of pigs in each group from which 
positive cultures of A. pleuropneumoniae were obtained is summarized in Table 
5. 
A summary of the clinical and pathological data is contained in Table 6. 
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Table 6: Clinical, pathological data and ranked data for pigs experimentally 

































2 0 39.9 0 25 1.35 19 49 17.5 52 53 
5 0 39.5 0 0 0.85 19 27 17.5 5.5 2.5 
6 0 39.8 0 0.4 0.94 19 45 17.5 14 8.5 
8 0 39.5 1 0.1 1.03 19 27 43.5 11 22 
10 0 40 3 54 2.5 19 54 58 57 57 
11 0 39 1 0 0.98 19 4.5 43.5 5.5 16 
12 0 39.4 0 0.5 1.06 19 17 17.5 18 27.5 
15 0 39.9 0 33 1.41 19 49 17.5 54 55 
16 0 39.5 1 11 1.07 19 27 43.5 47.5 32 
17 0 39.3 0 9 1.12 19 11 17.5 46 37 
18 0 39.5 0 0.8 0.9 19 27 17.5 24 5.5 
19 0 39.9 1 1.8 1.31 19 49 43.5 27.5 52 
20 0 39.2 0 3.9 1.04 19 7.5 17.5 36 24 
21 0 40 2 5.4 1.3 19 54 55 43 51 
24 0 40 0 1.8 0.97 19 54 17.5 27.5 13 
25 0 39.6 0 0.5 1.06 19 36.5 17.5 18 27.5 
26 0 39.5 0 0 1.01 19 27 17.5 5.5 18.5 
27 0 39.7 0 0.4 1.04 19 41.5 17.5 14 24 
28 0 39.5 0 0 0.85 19 27 17.5 5.5 2.5 
33 0 39 0 6.3 1.07 19 4.5 17.5 44 32 
36 0 39.6 0 2.5 1.21 19 36.5 17.5 31.5 48.5 
40 0 39.2 0 5.3 1.14 19 7.5 17.5 42 40.5 
41 0 39.7 0 0 1.14 19 41.5 17.5 5.5 40.5 
44 0 38.8 0 14 1.16 19 3 17.5 49 45 
45 0 39.8 0 49 2.04 19 45 17.5 56 56 
46 0 39.3 0 0.4 0.8 19 11 17.5 14 1 
47 0 39.1 0 1.6 0.97 19 6 17.5 26 13 
48 0 39.5 0 0.5 0.98 19 27 17.5 18 
16 
49 0 39.4 0 0 0.98 19 17 17.5 5.5 
16 
50 0 40.1 0 0.4 1.02 19 57 17.5 14 20.5 
51 0 39.5 0 4.6 1.14 19 27 17.5 
40 40.5 
52 0 40 0 11 1.17 19 54 17.5 
47.5 47 
53 0 39.6 1 0.4 1.08 19 36.5 43.5 14 
35 
55 0 39.5 1 0.7 1.16 19 27 43.5 22 
45 
56 0 39.6 0 4.2 1.01 19 36.5 17.5 
37 18.5 
58 0 39.9 0 2.5 1.04 19 49 17.5 
31.5 24 
59 0 39.7 0 2.3 0.97 19 41.5 17.5 
30 13 
1 1 39.5 1 3.6 1.21 45 27 43.5 
35 48.5 
4 1 39.9 1 27 1.27 45 49 43.5 
53 50 
7 1 39.5 1 2 0.95 45 27 
43.5 29 10.5 
9 1 39.5 1 21 1.16 45 27 
43.5 51 45 
14 1 39.4 0 2.6 1.15 45 17 
17.5 33.5 43 
23 1 39.6 2 0 0.9 45 36.5 
55 5.5 5.5 
29 1 39.5 1 7 0.95 45 27 
43.5 45 10.5 
31 1 38.7 2 4.3 1.07 45 2 
55 38 32 
34 1 39.4 1 2.6 1.07 45 17 
43.5 33.5 32 
35 1 39.3 0 0 0.93 45 11 
17.5 5.5 7 
38 1 39.3 0 4.7 1.14 45 11 
17.5 41 40.5 
42 1 39.4 1 0 1.02 45 17 
43.5 5.5 20.5 
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43 1 40 1 44 1.37 45 54 43.5 55 54 
54 1 39.7 1 1.5 1.06 45 41.5 43.5 25 27.5 
60 1 39.4 0 4.5 1.09 45 17 17.5 39 36 
3 2 39.4 1 0.6 1.06 55.5 17 43.5 20 27.5 
22 2 38.5 2 20 1.13 55.5 1 55 50 38 
30 2 39.3 0 0.7 0.94 55.5 11 17.5 22 8.5 
37 2 39.8 1 0 0.88 55.5 45 43.5 5.5 4 
39 2 39.6 2 0.7 1.07 55.5 36.5 55 22 32 
57 2 40.8 1 55.5 58 43.5 . 
N. B. consoln. = consolidation; Bwt = Bodyweight 
Two highly significant correlations were noted, between clinical demeanour score and 
respiratory score (Table 8), and between lung consolidation and lung/ bodyweight 
ratio (p<0.001) (Figure 2 and Table 8). It should be noted that for half the animals in 
this study, both the clinical demeanour score and the respiratory score were zero. 
However, a chi-square analysis of the two-way table of clinical demeanour score 
versus respiratory score, with both scores recorded as zero or non-zero, also provided 
highly significant evidence of an association between these two variables (p=0.001). 
None of the other pairwise correlations in this study were significant at the 5 percent 
level (Table 8). 
Table 7: Two-way table showing numbers of animals/ respiratory score at each 
clinical demeanour score for 58 pigs experimentally infected with A. 
pleuropneumoniae serotype 3 








29, 4 1 0 
6 9 3 0 
1 2 2 2 
1 0 0 0 
N. B. the two pigs euthanased within 30 hours of infection are 
highlighted in bold type 
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Figure 2: Graphical relationship between ranked data for lung/ bodyweight ratio 
(expressed as %) and ranked lung consolidation data for 60 pigs experimentally 
infected with Actinobacillus pleuropneumoniae serotype 3. 
60 









0 10 20 30 40 50 60 
Rank of lung consolidation 
N. B. Numbers next to plotted points indicate the number of identical values. 
Table 8: Spearman's correlation coefficients demonstrating the strength of 
correlation between rectal temperature, respiratory score, percent lung 
consolidation and lung: bodyweight ratio in 60 pigs experimentally infected with 
Actinobacillics pleuropneumoniae serotype 3 












PUK9501 Rectal temperature -0.13 (0.30) - - - - 
(n=58) Respiratory score 0.52 (<0.001) 0.11 (0.41) - - - 
% Lung consolidation 0.05 (0.72) 0.10 (0.45) 0.10 (0.44) - - 
Lung/bodyweight ratio -0.04 (0.76) 0.25 (0.06) 0.19 (0.15) 0.71 (<0.001) - 
(%) 
N. B. 
1. n=58 except for correlations involving percent lung consolidation and lung/ bodyweight ratio 
where n=57 
2. numbers in bold denote statistically significant correlations, where p<0.05 (p values are given 
in 
brackets) 
There was an insufficient range of clinical scores between the groups to correlate 
demeanour scores with production data such as Average Daily Feed Intake and Feed 
Conversion Ratio data. The median demeanour score for the total study period varied 
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between 11.0 and 18.5 (Table 2) while the median Feed Conversion Ratio's varied 
between 1.72 and 2.03 (Table 3). Many more groups would be needed to correlate 
data which has been measured on a group basis, such as feed intake. Median values 
are probably more applicable for comparison of demeanour score over the entire study 
period than the means, because group mean values are influenced more by individual 
extreme cases and do not reflect the `group' as well. There were insufficient data to 
evaluate the group effects on production data, and this is outwith the scope of this 
thesis, but it would make interesting additional research provided a sufficient number 
of replicated groups under similar conditions were available. 
Figure 3: Graphical representation of the relationship between clinical 
demeanour score and respiratory score, percent lung consolidation and mean 
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Study 2: PBE9501 
Overview 
Forty eight-week-old pigs were divided at random into five groups of eight pigs. 
Each group of pigs was housed in a separate room. The pigs were inoculated intra- 
nasally with 107 cfu of an A. pleuropneumoniae serotype 5a strain. All pigs were 
examined daily for clinical disease. Clinical demeanour and respiratory signs were 
scored daily. Rectal temperatures were recorded daily. Pigs that died after 
infection were necropsied immediately. Pigs with severe respiratory distress, 
lethargy or weakness were euthanased. Surviving pigs were euthanased for post 
mortem examination 9-10 days after infection and examined for lung lesions and 
presence of A. pleuropneumoniae in the lung. Data were then examined for 
correlation between clinical demeanour and respiratory scores with each other and 
with rectal temperature, percent lung consolidation, and the lung to bodyweight 
ratio which was expressed as a percent. 
Materials and methods 
Forty pigs were obtained from a single herd with no history of Actinobacillosis. 
Blood samples were taken at three and five weeks-old and tested for antibodies 
against A. pleuropneumoniae RTX toxins ApxI and ApxII as described by Dom et 
al. (1994a), to ensure that there was no pre-existing episode of Actinobacillosis 
which might obscure the interpretation of the infection experiment. 
At four weeks-old, pigs were transported to the animal house and divided at 
random into five groups of eight pigs each, according to the same stratified 
randomisation procedure as used in Study 1. 
On the day of arrival, all pigs were weighed and identified by a uniquely numbered 
114 
eartag. The pigs were then allowed to acclimatize for four weeks. 
Pigs were inoculated intranasally with 107 cfu of an A. pleuropneumoniae serotype 
5a strain. Nine days after infection, half of the remaining pigs in each pen were 
euthanased and necropsied. The other pigs were necropsied at ten days post- 
infection. This was due to the time constraints of conducting this number of 
necropsies. Weighing of the pigs was performed three times: at the day of arrival 
(four weeks of age), at six weeks of age and at necropsy (ten weeks of age). 
Sera were tested for neutralizing antibodies against ApxI and ApxII produced in 
recombinant Escherichia coli using a bioassay based on neutral red uptake by 
viable pulmonary alveolar macrophages (PAM) and titres of antibodies against 
ApxI were determined as described by Dom et al. (1994b). 
Antibodies against Apxl and ApxII had been detected in 39 percent and 66 percent 
of the blood samples taken five weeks before infection. Therefore, blood samples 
were taken three weeks before the beginning of the study to differentiate between 
antibodies of active and passive immunity against A. pleuropneumoniae. 
The important events in the study are summarised in the following schedule: 
Schedule of events: 
Day 1 Take rectal temperatures 
Day 2 Take rectal temperature, measure water intake, weigh pigs, 
experimental infection of animals 
Days 3-10 Clinical scores, rectal temperatures, water intake 
Day 11 Euthanase and necropsy first half of surviving pigs 




Results are summarized in Table 9. At 36 days before infection, antibodies against 
ApxI and ApxII were detected in 39 percent and 66 percent of the animals, 
respectively. At 21 days before infection, these had declined to 25 percent and 35 
percent against ApxI and ApxII, respectively. Since titres of antibodies and 
number of animals with antibodies was higher at 36 days before inoculation, those 
antibodies were likely to be of maternal origin. 
Table 9: Results of serological testing for antibodies against Apx I and Apx II 
toxins at 36 and 21 days prior to inoculation for five groups of eight pigs prior to 
experimental infection with A. pleuropneumoniae serotype 5a 
Number of pigs with antibodies against 
ApxI and ApxII/total number of pigs (%) at 
36 days before inoculation 21 days before inoculation 
Group ApxI ApxII Apxl ApxII 
1 2/5 (40) 4/5 (80) 1/8 (13) 2/8 (25) 
2 4/7 (57) 5/7 (71) 3/8 (38) 3/8 (38) 
3 4/7 (57) 4/7 (57) 2/8 (25) 2/8 (25) 
4 1/7 (14) 6/7 (86) 2/8 (25) 4/8 (50) 
5 2/7 (29) 2/6 (33) 2/8 (25) 3/8 (38) 
mean 
percentage 39% 66% 25% 35% 
Feed Intake 
The animals consumed all of the allocated 65 g 
feed per kilogram bodyweight each 
day. During the experimental study period, every pen therefore consumed 
190 kg 
of grower food. Water intake data is summarised 
in Table 10. 
116 
Disease signs 
Disease signs were not observed before inoculation. Pigs in all groups developed 
fever and disease signs shortly after inoculation. In addition, average rectal 
temperature and clinical demeanour scores for days six to ten days after inoculation 
were closely aligned with the average percent lung lesions found at necropsy. 
Necropsy findings 
Results are summarised in Table 11. It can be seen that total lung weight was 
lowest in group 4. In groups 2 and 4, the number of pigs with lung lesions was 
lower than in other groups. The mean percentage of lung tissue with lesions was 
also lower in these groups. 
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Table 10: Daily water usage by five groups of eight pigs after experimental 
infection with A. pleuropneumoniae serotype 5a 
Days after Daily Water Usage (litres) per group 
infection 
Group 1 Group 2 Group 3 Group 4 Group 5 
0 17.5 12.25 17 19 13.75 
1 18 26.25 15.75 35 13.5 
2 21.75 21.75 17.25 28 15.75 
3 18 23 13.75 23.25 16.75 
4 17.5 19.75 13.75 12.25* 15.75 
5 17.75 22.5 15.75 26.75 16 
6 18.25 21.5 12.75 -* 15.25 
7 16 19.25 15.5 26.75 15.25 
8 15 23 15 25.5 14.5 
9 15 21.5 13.25 26 13 
Mea n 17.5 21.1 15 26.3 ** 15 
N. B. * Due to a malfunction of the drinking water system, the barrel with drinking water ran 
empty on both occ asions and so w ater uptake could not be measured. 
** This mean was calculated without the water intake on Days 6 and 8. 
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Table 11: Necropsy findings and bacteriology results for five groups of eight 
pigs experimentally infected with A. pleuropneumoniae (APP) serotype 5a 
Number of pigs/ Mean percentage Total number with positive 
Total total number with abcess- of lung tissue with isolation of APP/ Number of pigs 
lungweight like nodules or pneumonia lesions sampled for the following tissues: 
Group (kg) (%) (%) Lungs Nostrils/tonsils 
1 4.6 5/8 (63) 20 5/8 (63) 0/8 (0) 
2 4.2 2/8 (25) 6 1/8 (13) 0/8 (0) 
3 5.1 5/8(63) 23 6/8(75) 1/8(13) 
4 3.8 2/8 (25) 1 2/8 (25) 1/8 (13) 
5 4.9 5/8 (63) 14 6/8 (75) 0/8 (0) 
Bacteriology 
Results are summarized in Table 11. From this table it can be concluded that A. 
pleuropneumoniae was isolated from lungs of pigs in all groups. The number of 
lungs from which A. pleuropneumoniae was isolated was lowest in groups 2 and 4. 
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Bodyweight 
Results are summarized in Table 12. 
Table 12: Summarized clinical, growth and pathological data for five groups 




1 2 3 4 5 
Deaths 1 0 1 0 0 
Mean rectal 1-4 40.1 40.1 39.9 39.6 39.9 
Temperature (°C) 5-9 39.8 39.4 39.9 39.2 39.8 
Mean clinical 1-4 0.82 0.44 1.09 0.67 0.91 
Score 5-9 0.46 0.25 0.46 0.08 0.50 
Lung Weight (g) 9-10 577 530 633 478 613 
(% of bodyweight) 2.92 2.70 3.36 2.37 2.85 
Percent Lung Lesions 9-10 20.0 5.6 23.1 1.3 14.4 
Bodyweight -18 9.5 9.9 9.2 
9.3 9.0 
(kg) 9 20.1 19.9 19.6 20.1 21.3 
Weight Gain (kg) 10.6 10.0 10.4 10.8 12.3 
(27 days) 
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In some animals, equally distributed between different groups, antibodies were 
detected at 21 days before inoculation. Since antibody titres and seroprevalence 
were higher 36 days before inoculation, those antibodies were more likely of 
maternal origin. This situation reflects the field situation since the prevalence of A. 
pleuropneumoniae is very high in Belgium (Dom et al. 1994b), where this study 
was conducted. All animals, including those with neutralising antibodies, showed 
febrile or clinical responses after infection. 
One pig developed peracute pleuropneumonia and died after experimental 
infection. All other animals developed acute disease. A. pleuropneumoniae was 
re-isolated from the lungs from at least one animal in every group. This indicates 
that the experimental infection model worked. 
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Table 13: Clinical and pathological data and ranked data from pigs 




































0 39.9 0 20 2 1 19 27.5 16.5 12.5 4 30.5 
0 39.9 0 95 3.6 1 19 27.5 16.5 35.5 33 30.5 
0 40.9 0 60 5.2 1 19 37 16.5 28.5 40 30.5 
0 40.3 1 35 2.3 1 19 33.5 35.5 17 9 30.5 
0 40 0 85 2.7 1 19 30 16.5 33 21 30.5 
0 39.6 0 2.5 2.6 0 19 21.5 16.5 6 17 10.5 
0 40.1 1 0 2.2 0 19 31 35.5 1.5 6.5 10.5 
3 41 3 70 2.4 0 39.5 38.5 39.5 30 12.5 10.5 
0 39.1 0 50 1.8 0 19 3 16.5 23.5 2 10.5 
0 39.2 0 50 2.9 0 19 4.5 16.5 23.5 25 10.5 
0 38.9 0 25 2.7 0 19 1.5 16.5 14 21 10.5 
0 39.2 0 5 3 0 19 4.5 16.5 8 28.5 10.5 
0 39.4 0 90 4 1 19 9 16.5 34 35.5 30.5 
0 39.4 0 55 3 0 19 9 16.5 26.5 28.5 10.5 
0 38.9 0 0 1.4 0 19 1.5 16.5 1.5 1 10.5 
0 39.7 0 40 3.4 0 19 25 16.5 19.5 31 10.5 
0 39.6 0 1 4 1 19 21.5 16.5 3 35.5 30.5 
0 39.9 0 20 3 1 19 27.5 16.5 12.5 28.5 30.5 
0 39.9 0 45 3 0 19 27.5 16.5 22 28.5 10.5 
0 39.4 0 100 4.3 1 19 9 16.5 39 38.5 30.5 
3 41 3 100 2.6 0 39.5 38.5 39.5 39 17 10.5 
0 40.3 0 18 2.9 1 19 33.5 16.5 11 25 30.5 
0 40.4 1 95 4.2 1 19 35.5 35.5 35.5 37 30.5 
0 39.4 1 55 2.8 1 19 9 35.5 26.5 23 30.5 
0 39.6 0 30 2.6 0 19 21.5 16.5 15 17 10.5 
0 39.4 0 2 2.6 0 19 9 16.5 4.5 17 10.5 
0 39.4 0 35 2.7 0 19 9 16.5 17 21 
10.5 
0 39.5 0 4 2.2 0 19 15.5 16.5 7 6.5 
10.5 
0 39.6 0 35 2.3 0 19 21.5 16.5 17 
9 10.5 
0 39.5 0 40 2 0 19 15.5 16.5 19.5 
4 10.5 
0 39.5 0 2 2 1 19 15.5 16.5 4.5 
4 30.5 
0 41.3 0 97 2.3 1 19 40 16.5 37 
9 30.5 
0 40.2 1 42 2.6 1 19 32 35.5 21 
17 30.5 




5 39 0 100 3.7 1 19 15.5 16.5 39 
34 30.5 
0 




4 39 1 75 4.3 1 19 9 35.5 31.5 
38.5 30.5 
0 




5 39 0 54 2.4 1 19 15.5 16.5 
25 12.5 30.5 
1 
. 
39.6 0 75 3.5 0 38 21.5 16.5 
31.5 32 10.5 
N. B. consoln. = consolidation; Bwt = Bodyweight 
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The correlation between lung consolidation and lung/bodyweight ratio was highly 
significant (p=0.005), yet, Figure 4 also illustrates that there is much individual 
variability, and that the correlation should only be assumed when analysing group 
data. Three other correlations were significant at the 5 percent level: rectal 
temperature was positively correlated with respiratory score (Figure 5 and Table 21 a), 
and bacteriological isolation (Table 21 a) was positively correlated with both lung 
consolidation and lung/bodyweight ratio (Figures 4 and 6). Correlation coefficients 
involving clinical score were not calculated as there were only three animals in this 
study with non-zero scores. 
Figure 4: Graphical illustration of the relationship between ranked data for 
lung/bodyweight ratio and lung consolidation for 40 pigs experimentally infected 
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123 
Figure 5: Graphical illustration of the relationship between ranked data for 
respiratory score and rectal temperature for 40 pigs experimentally infected with 
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Figure 6: Graphical representation of the relationship between ranked data for 
bacteriological reisolation and lung/ bodyweight ratio for 40 pigs experimentally 
infected with A. pleuropneumoniae serotype 5a 
40 
v2222L2 




0 101""0" """" "" 
m 
0I f-ý 
0 10 20 30 40 
Rank of lung/bodyweight ratio 
N. B. Numbers next to plotted points indicate the number of identical values. 
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Study 3-Pigs (NE9501) 
Overview 
Fifty specific-pathogen-free (SPF) pigs were used in this study. The pigs were 
selected and weighed when they were approximately eight-weeks-old. Groups of ten 
pigs were split between two replicates. 
In the early morning of Day 9, every pig was endobronchially inoculated with 10' A. 
pleuropneumoniae serotype 9. First clinical signs were observed 6-8 hours after 
challenge and all pigs were `very dull' (demeanour score 3) 12 hours after challenge. 
All pigs were dyspnoeic with abdominal breathing, and an increased respiratory rate. 
All but one pig was pyrexic. Marked coughing was observed in all experimental 
groups. Vomitus was found on the floor of all pens. Twenty-four hours after 
challenge, most of the pigs were `severely diseased' (demeanour score 4). It was 
decided to euthanase the `severely diseased' pigs for welfare reasons. Remaining pigs 
were euthanased the next day. At necropsy, lungs of all pigs had typical lesions with 
haemorrhages, necrosis and fibrin. A. pleuropneumoniae serotype 9 was isolated from 
all swab specimens taken from the lung lesions from all pigs. Additional to the 
data 
examined in the previous two studies (i. e. clinical demeanour score: rectal 
temperature; respiratory score; percent lung consolidation; lung/bodyweight ratio), 
cough score, weight gain, tracheo-bronchial, thoracic and sternal 
lymph node 
enlargement were also examined as potential indicators of disease severity. 
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Materials and methods 
A. pleuropneumoniae strain 13261, serotype 9 was used. The strain was originally 
isolated from a lung of a pig from a recent field case of pleuropneumonia. A 
laboratory strain was passed through an SPF-pig and the first passage of strain was 
stored in Eagle's Minimal Essential Medium supplemented with Earle's salts (EMEM; 
ICN-Flow lab. ) at -70°C. One vial with a suspension of A. pleuropneumoniae 13261 
was thawed from - 70°C .A 
heart infusion agar plate supplemented with 5% 
defibrinated sheep blood and 0.2% nicotinamide adenine dinucleotide (HIS+V plate) 
was inoculated with a loopful of this suspension. The plate was incubated overnight 
at 37°C and 5% CO2. The next morning 5 haemolytic colonies were suspended in 1 
ml EMEM. This suspension was heavily inoculated on 2 HIS+V plates by use of a 
cotton swab. These plates were incubated for 8 hours at 37°C at 5% CO2. Then, 
bacterial growth was washed off with 5 ml EMEM per plate. Washings were pooled. 
One sample was used for a Gram-stain and confirmed that the pool consisted only of 
small Gram negative rods. Another sample was agglutinated with an antiserum 
against A. pleuropneumoniae serotype 9 and confirmed that it was serotype 9. 
Duplicates of ten-fold serial dilutions of another sample were plated on HIS+V to 
determine the number of Colony Forming Units (CFU). The remainder of the pooled 
suspension was stored at 4°C. The next morning, the number of CFU was counted 
and the inoculum was prepared by diluting the bacterial suspension in EMEM to a 
concentration of approximately 103 bacteria per ml. This dose was expected to give 
100% morbidity and approximately 30% mortality in the untreated control group 
based upon previous investigators use of a similar infection protocol 
(Pijpers et al. 
1990a, 1990b, Mengelers et al. 1991). A 1000: 1 dilution of this inoculum was plated 
on HIS+V to confirm the number of CFU. The inoculum was 
divided into five bottles, 
one for each MPB. The inoculum was transported on 
ice to the MPBs and what was 
left after inoculation was returned to the laboratory. Again a 
1000: 1 dilution of this 
inoculum was plated on HIS+V to check the number of viable 
bacteria. 
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Inoculation of the pigs 
Pigs were inoculated early in the morning of Day 9 of the experiment. 
Pigs were anaesthetised by an open inhalation system. A cone-shaped face mask was 
fixed upon the pig's nose and a gas mixture of 48% oxygen, 48% nitrous oxide and 
4% halothane was administered for 3-4 minutes. The gas flow was fixed at 2000 ml 
per minute for both oxygen as well as nitrous oxide. Then, the mask was removed and 
the pig was held with the head in a vertical position. The pig's mouth was held open 
with a gag. A laryngoscope was introduced in the mouth and used to press down the 
epiglottis. A sterile stiff catheter (Cordis Europe, Etten Leur, The Netherlands) was 
introduced into the trachea until some resistance was felt. Ten millilitres of the 
inoculum was slowly injected via the catheter deep into the lung with a 10 ml disposa- 
ble syringe (Terumo Europe, Leuven Belgium). The catheter was then quickly 
withdrawn. 
Bacteriological examination of lung samples after necropsy 
Swab samples from lung lesions were cultured on HIS +V plates. Plates were 
incubated overnight at 37°C and 5% CO2. Two to three haemolytic colonies were 
tested in a slide agglutination assay with antiserum directed against A. 




The number of bacteria in the challenge dose was counted before and after 
inoculation. Bacterial counts varied from 1.2x103 to 1.8x103 per ml. 
Water intake 
Daily water intakes before challenge were similar for all groups, after inoculation 
water intake for all groups dropped to between 23 percent and 38 percent of the pre- 
inoculation intakes, indicating the effect that A. pleuropneumoniae may have on 
water intake (Table 14). There was no anaesthetised, non-inoculated control group, so 
it cannot be judged what effect the anaesthesia may have had in depressing water 
intake. 
Table 14: Water intake in litres per day for groups of ten pigs up to and 
including the day of endobronchial inoculation with A. pleuropneumoniae 
serotype 9 (Day 9) 
Group 
Day 1 2 3 4 5 
5 16.6 16.3 11.6 13.9 14.7 
6 30.2 25.0 20.9 25.2 25.7 
7 15.1 13.5 10.7 12.8 12.5 
7 19.6 19.7 10.4 14.5 12.4 
8 37.2 32.0 28.5 28.3 
37.4 
9 14.0 9.0 7.2 5.5 
8.7 
Feed uptake and weight gains 
Feed uptake of the groups were similar in the period before challenge, as were weight 
gains during this period (Table 15). After challenge weight gains were reduced 
and 
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many pigs lost weight even in the short period between inoculation and euthanasia 24 
to 48 hours later (Table 15). The mean daily weight gain is given in Table 16 for each 
group. 
Table 15: Feed uptake and weight gains (kilograms) for groups of ten pigs 
experimentally infected with A. pleuropneumoniae serotype 9 




gain day 0-8 
(kg) 
mean weight gain after challenge (a. c. ) of pigs 
euthanased 
one day a. c. two days a. c. 
1 107.5 4.5+ 1.5 0.1 + 1.6 
2 99.6 4.7+0.9 -0.4+0.9 -0.6 ± 1.0 
3 96.0 4.2+0.9 -0.6+0.7 -0.9+0.6 
4 93.8 4.8+2.1 -0.7+0.8 -0.1 ± 1.8 
5 110.8 5.4+ 1.5 0.5+ 1.4 0.4+2.1 
Table 16: Mean daily weight gains of the pigs (kilograms) for groups of ten pigs 
experimentally infected with A. pleuropneumoniae serotype 9 
mean weight gain per day 
before challenge 
(kg) 
mean weight gain (kg) per day after challenge of pigs 
euthanased at 
Group Day 10 Day 11 
1 0.57±0.19 0.07±0.8 - 
2 0.59±0.11 -0.21 ±0.43 -0.16±0.40 
3 0.52+0.12 -0.37 ± 0.33 -0.43 
4 0.59+0.26 -0.33+0.42 -0.04+0.60 
5 0.67±0.19 0.25* 
0.04±0.58 
* too few data to calculate a standard deviation. 
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Clinical observations 
First clinical signs of respiratory disease were observed approximately 6-8 hours after 
challenge when all pigs had demeanour scores 2 and 3. All had dyspnoea with 
abdominal breathing, and an increased respiratory rate. Marked coughing was 
observed in all experimental groups. Vomitus was found on the floor of all pens and 
some pigs were seen vomiting. Clinical scores were high in all groups and all pigs 
had typical lesions at necropsy from which A. pleuropneumoniae was isolated in pure 
culture. 
Necropsy findings 
Except for pig 2298, all pigs that were euthanased one day after challenge had large 
quantities of exudate with fibrin in the pleural cavity. Most pigs that were euthanased 
on the second day after challenge had severe pleuritis with much fibrin in the pleural 
cavity. Lungs of all pigs had characteristic lesions with haemorrhages, necrosis and 
fibrin. 
In general, thoracic lymph nodes of all but one pig (2295) were enlarged (lymph node 
score 1-3). Peritoneal cavities, spleens, and hearts of pigs in all groups appeared 
macroscopically normal or slightly enlarged. The kidneys and liver of many pigs of 
all groups were swollen. 
A summary of the clinical and pathological data is given in Table 
17, and the ranked 
data used to graphically correlate it in Table 18. 
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Table 17: Summarised clinical data for 50 pigs artificially infected with A. 
pleuropneumoniae serotype 9 
PNE9501 
Pig no. Clinical Rectal Resp. Lung Lung/ Cough Weight Tracheo Thoracic Sternal 
score Temp. score consoln. Bwt Score gain (%) bronchial lymph aortic 
(°C) (%) ratio lymph node node lymph 
score score node 
score 
2281 3 41.1 2 40 2.10 0 47.73 2 2 1 
2282 3 40.1 3 10 1.25 0 40.00 1 1 1 
2283 3 42 2 40 1.96 2 37.89 3 2 1 
2284 3 40.7 2 40 1.89 2 46.32 2 2 1 
2285 3 40.3 2 50 1.87 2 40.53 3 2 1 
2286 4 40.6 2 30 1.56 2 43.24 2 2 1 
2287 3 40.9 1 25 1.14 2 43.92 3 2 1 
2288 3 41.2 3 40 2.64 2 38.06 2 1 2 
2289 3 40.7 2 40 1.71 0 48.39 2 2 1 
2291 3 40.7 3 25 1.09 2 37.83 2 2 1 
2292 3 41.3 2 40 1.62 0 36.52 3 2 1 
2293 3 40.4 3 , 40 2.07 
1 20.87 2 2 1 
2294 3 40.8 2 60 2.00 0 43.00 2 2 1 
2295 3 40.2 2 2.5 0.91 0 56.50 0 0 0 
2296 3 41.9 2 40 1.50 2 36.32 3 2 1 
2297 3 40.4 2 40 1.69 0 39.47 2 2 1 
2298 2 40 2 5 0.96 0 57.14 1 1 0 
2299 3 40.7 3 15 1.10 2 61.71 3 2 1 
2301 3 40.2 2 40 1.69 0 43.48 2 2 1 
2302 3 41.5 2 40 1.46 2 37.27 2 1 1 
2303 3 39.9 2 60 3.08 2 30.48 3 2 1 
2304 3 40.7 3 60 2.68 0 50.50 2 1 1 
2305 3 41.4 2 30 1.29 0 44.62 2 1 1 
2306 3 40.7 2 40 1.79 2 54.36 2 2 1 
2307 3 41.4 2 40 1.98 2 42.63 2 2 1 
2309 3 41 2 25 1.85 2 44.78 2 2 1 
2310 3 41 2 30 1.59 0 18.70 2 2 1 
2311 3 40.2 2 30 1.07 0 42.79 2 1 1 
2312 3 42.1 2 30 1.82 0 36.50 2 2 1 
2313 4 40.8 3 30 1.62 2 36.00 3 2 1 
2314 3 40.9 1 40 1.69 2 50.26 2 2 
1 
2315 3 39.8 2 25 1.39 0 45.26 3 2 1 
2316 3 40.9 2 25 1.15 2 43.24 2 
2 1 
2317 4 41.4 2 50 1.86 0 46.67 2 2 
1 
2318 3 41.4 2 30 1.71 0 40.00 2 
1 1 
2319 3 40.8 2 50 1.59 2 48.44 2 1 
2 
2320 3 40.7 2 33 1.35 1 42.73 2 
0 2 
2321 3 40.7 2 40 1.23 2 36.82 2 
2 
2322 2 41.3 1 40 1.62 0 31.63 2 
2 
2323 3 40.3 3 15 0.95 0 42.38 
2 2 
2324 3 40.4 2 50 2.88 2 33.33 
2 2 
2325 3 39.6 2 8 0.87 0 55.14 2 
1 0 
2326 3 40.5 2 40 1.89 2 38.38 3 
3 
2327 3 40.3 2 40 1.74 0 50.00 
? 2 
2328 3 39.6 2 20 1.34 0 26.05 3 
2 
2329 4 40.4 2 30 1.57 0 36.19 
3 3 
2330 4 39.7 2 10 1.31 0 33.33 
3 2 2 
2331 4 41.5 3 70 2.96 2 39.05 
2 1 
131 
2332 3 41.7 2 40 1.85 1 32.22 22 
2333 3 40.9 2 40 1.59 1 31.58 22 
N. B. consoln. = consolidation; Bwt = Bodyweight 
Table 18: Ranked data for 50 pigs artificially infected with A. pleuropneumoniae 
serotype 9 
NE9501 RANKS RANKS RANKS RANKS RANKS RANKS 
Pig no. Clinical Rectal Resp. Lung Lung/ Cough 
score Temp. score consoln. Bwt 
(°C) (%) ratio 
2281 23.5 37 22.5 32.5 45 12.5 
2282 23.5 7 46 4.5 11 12.5 
2283 23.5 49 22.5 32.5 41 39.5 
2284 23.5 23.5 22.5 32.5 40 39.5 
2285 23.5 12 22.5 44.5 38 39.5 
2286 47.5 19 22.5 17.5 19 39.5 
2287 23.5 32.5 2 11 8 39.5 
2288 23.5 38 46 32.5 46 39.5 
2289 23.5 23.5 22.5 32.5 31 12.5 
2291 23.5 23.5 46 11 6 39.5 
2292 23.5 39.5 22.5 32.5 25 12.5 
2293 23.5 15.5 46 32.5 44 26.5 
2294 23.5 29 22.5 48 43 12.5 
2295 23.5 9 22.5 1 2 12.5 
2296 23.5 48 22.5 32.5 18 39.5 
2297 23.5 15.5 22.5 32.5 29 12.5 
2298 1.5 6 22.5 2 4 12.5 
2299 23.5 23.5 46 6.5 7 39.5 
2301 23.5 9 22.5 32.5 27 12.5 
2302 23.5 45.5 22.5 32.5 17 39.5 
2303 23.5 5 22.5 48 50 39.5 
2304 23.5 23.5 46 48 47 12.5 
2305 23.5 42.5 22.5 17.5 12 12.5 
2306 23.5 23.5 22.5 32.5 33 39.5 
2307 23.5 42.5 22.5 32.5 42 39.5 
2309 23.5 35.5 22.5 11 35 39.5 
2310 23.5 35.5 22.5 17.5 23 12.5 
2311 23.5 9 22.5 17.5 5 12.5 
2312 23.5 50 22.5 17.5 34 12.5 
2313 47.5 29 46 17.5 26 39.5 
2314 23.5 32.5 2 32.5 28 39.5 
2315 23.5 4 22.5 11 16 12.5 
2316 23.5 32.5 22.5 11 9 39.5 
2317 47.5 42.5 22.5 44.5 37 12.5 
2318 23.5 42.5 22.5 17.5 30 12.5 
2319 23.5 29 22.5 44.5 22 39.5 
2320 23.5 23.5 22.5 22 15 26.5 
2321 23.5 23.5 22.5 32.5 10 39.5 
2322 1.5 39.5 2 32.5 24 12.5 
2323 23.5 12 46 6.5 3 12.5 
RANKS RANKS 
Weight Tracheo 



























































































2324 23.5 15.5 22.5 44.5 48 39.5 8.5 20.5 31 25 
2325 23.5 1.5 22.5 3 1 12.5 47 20.5 8 2 
2326 23.5 18 22.5 32.5 39 39.5 20 44 49.5 25 
2327 23.5 12 22.5 32.5 32 12.5 43 20.5 31 25 
2328 23.5 1.5 22.5 8 14 12.5 3 44 31 25 
2329 47.5 15.5 22.5 17.5 20 12.5 11 44 49.5 25 
2330 47.5 3 22.5 4.5 13 12.5 8.5 44 31 48.5 
2331 47.5 45.5 46 50 49 39.5 21 20.5 8 25 
2332 23.5 47 22.5 32.5 36 26.5 7 20.5 31 25 
2333 23.5 32.5 22.5 32.5 21 26.5 5 20.5 31 25 
N. B. consoln. = consolidation; Bwt = Bodyweight 
The strongest correlation was between lung consolidation and lung/bodyweight ratio 
(Spearman's coefficient, 0.79; p<0.001) (Figure 7 and Table 21b). Temperature 
showed statistically significant correlations with both of these parameters, but these 
relationships were not very strong. 
Figure 7: Graphical illustration of the relationship between ranked data for 
lung/ bodyweight ratio and lung consolidation for 50 pigs artificially infected 
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The scores for tracheo-bronchial and thoracic lymph nodes showed a 
highly 
significant positive correlation (p<0.001) (Table 19 and Table 
21b). Weight gain 
showed statistically significant negative correlations with 
both of these parameters 
even over the short interval between infection and euthanasia 
due to the near total 
inappetance of pigs (Table 21 b). The only other correlation significant at the 
5 
percent level was between clinical score and tracheo-bronchial 
lymph nodes (Tables 
20 and 21b). 
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Table 19: Two way table showing relationship between increase in lymph node 
size for tracheo-bronchial and thoracic lymph nodes for 50 pigs artificially 
infected with A. pleuropneumoniae serotype 9 
No. of 
animals 
Tracheo bronchial lymph nodes 
0 or 123 
Thoracic 
lymph nodes 
0 1 1 0 
1 2 9 0 
2 0 24 11 
3 0 0 2 
Table 20: Two way table showing numbers of pigs infected with A. 
pleuropnettinoniae with hyperplasia of the tracheo-bronchial lymph nodes at 
increasing clinical scores for 50 pigs artificially infected with A. pleuropneumonia 
serotype 9 
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Discussion (Study 3) 
A model in which SPF pigs were deeply endobronchially inoculated with 
A. 
pleuropneuinoniae serotype 9 at a challenge dose of approximately 
104 bacteria per 
pig was chosen because this dose gave 100 percent morbidity. 
After challenge, all pigs became very dull (score 3) within 12 
hours. Water intake and 
feed intake was markedly reduced after challenge. The animal model used 
is clearly a 
severe model and this limited its usefulness. The natural 
infection route of A. 
pleuropneuinoniae in pigs is aerogenous. In this model, 
bacteria were inoculated 
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directly deep into the bronchi and thus the defence mechanisms of the upper 
respiratory tract were circumvented. The advantage of endobronchial inoculation 
model is that it is very reproducible and gives 100 percent morbidity in control pigs. 
Furthermore, the number of bacteria that reach the lungs is known. The model has 
been used extensively elsewhere to prove protection of vaccination (Kamp et al. 1992) 
and to study the effects of in-feed medication with tetracyclines and combinations of 
sulfonamides and trimethroprim (Pijpers et al. 1990a, 1990b, Mengelers et al. 1991). 
In these studies, the challenge doses were 104 CFU/pig, but conventional pigs instead 
of SPF-pigs were used. Conventional pigs appear to be less susceptible than SPF-pigs 
and higher challenge doses are needed for similar severity of disease to be obtained. 
Quantification of the inoculum titre after inoculation showed that pigs were inoculated 
with approximately 103 CFU per pig instead of the intended 104 CFU/pig which had 
been used previously in this model. Nevertheless, the disease severity was higher 
than in previous studies. This may be partly due to the fact that SPF pigs were used, 
and they may be more susceptible to infection. 
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Statistical analysis and discussion of pig study results 
A number of variables from three different studies were available for analysis. In the 
first study, PUK9501, the variables were: 
Clinical (demeanour) score 
Temperature 
Respiratory score 
Percent lung consolidation 
Lung/bodyweight ratio (%) 
There were 58 animals with data available from this study, but one animal did not 
have data recorded for the last two of the above variables. Hence, the pairwise 
correlations were calculated from 57 or 58 observations, according to the data 
available. 
In the second study, PBE9501, the same variables as listed above were available, and 
in addition bacteriological reisolation (O=no, 1=yes) was recorded. There were 40 
animals in this study. However, the clinical score was zero for all but three of these 
animals, and so this variable has not been included in the correlation analysis for 
PBE9501. 
In the third study, PNE9501, the same variables as in PUK9501 were recorded, as 
well as a number of additional variables: 
Cough score 
Weight gain (%) 
Tracheo-bronchial lymph node score 
Thoracic lymph node score 
Sternal aortic lymph node score 
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There were 50 animals in this study. One lung consolidation value was recorded as 
`<5' and this has been set to 2.5 percent so that this observation could be used in the 
analysis. 
The results presented consist of correlation coefficients and p-values for each pair of 
variables. In each case, Spearman's correlation coefficient was calculated, i. e. given n 
pairs of observations (x; , y; ) (i=1,2,..., n) 
for two variables x and y the coefficient is: 





. _ý ; =t 
where r; denotes the rank of x;, s; denotes the rank of y;, and r ands denote the mean 
values of the ranks of x and y respectively. The p-value was obtained by calculating 
the probability of obtaining a correlation at least as big as the one observed for the 
given number of observations, under the hypothesis of there being no relationship 
between the two variables. This was done automatically using the CORR procedure 
in the SAS for Windows (Version 6.12) package. In the tables of results, correlations 
significant at the 5 percent level have been highlighted in bold (Tables 21 a and 21 b). 
In study PUK9501, two highly significant correlations were noted, between clinical 
score and respiratory score, and between lung consolidation and lung/ bodyweight 
ratio (p<0.001). It should be noted that for half the animals in this study, 
both the 
clinical score and the respiratory score were zero. However, a chi-square analysis of 
the two-way table of clinical score versus respiratory score, with both scores recorded 
as zero or non-zero, also provided highly significant evidence of an association 
between these two variables (p=0.001). None of the other pairwise correlations 
in this 
study were significant at the 5 percent level. 
In study PBE9501, the correlation between lung consolidation and 
lung/ bodyweight 
ratio was also highly significant, although not as strong as 
in the first study. Three 
other correlations were significant at the 5 percent 
level: temperature was positively 
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correlated with respiratory score, and bacteriological isolation was positively 
correlated with both lung consolidation and lung/ bodyweight ratio. However, these 
positive correlations were not very strong. Correlations involving clinical score were 
not calculated as there were only three animals in this study with non-zero scores. 
In study PNE9501, the strongest correlation was again between lung consolidation 
and lung/ bodyweight ratio. Temperature showed statistically significant correlations 
with both of these parameters, but these relationships were not very strong. 
The scores for tracheo-bronchial and thoracic lymph nodes showed a highly 
significant positive correlation (p<0.001). Weight gain showed statistically 
significant negative correlations with both of these parameters, but these relationships 
were not strong. The only other correlation significant at the 5 percent level was 
between clinical score and tracheo-bronchial lymph nodes. 
Care should be taken in the interpretation of statistical significance, particularly in the 
PNE9501 study, due to the number of tests being performed. 
Looking at the three studies together, the positive correlation between lung 
consolidation and lung/ bodyweight ratio was consistent across the three studies, but 
there were many differences in terms of the other parameters. On pooling the data 
there were significant differences between the three studies in the relationships 
between the variables. Hence, calculating correlation coefficients for the combined 
data is not appropriate, and so these additional results have not been presented. These 
studies suggest that for A. pleuropneumoniae infections in pigs, clinical 
demeanour 
and respiratory scores do not give a reliable indication of the pathology occurring 
in 
the animal. 
Figure 8 illustrates the different relationships observed with each serotype of A. 
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Part of the reason for the different relationship between clinical and pathological 
measures is likely to be due to a difference in the virulence of different serotypes of A. 
pleuropneunion iae, and the release of different amounts of the RTX toxins. The 
deleterious effects of these proteins secreted by A. pleuropneumoniae have been 
demonstrated to be toxic to porcine erythrocytes, endothelial cells, macrophages and 
neutrophils (Udeze et al. 1987; Dom et al. 1994c). The differences in relationship in 
Figure 8 may also be due to the fact that pigs with per-acute signs were euthanased 
before the gross manifestation of the pathology were evident. Pigs with milder 
clinical signs survived until the end of the study and abscess formation in the lungs 
therefore developed further over the subsequent 14 days. In Study 3 (PNE9501), all 
pigs were necropsied at a similar interval after infection which possibly accounts for 
the more linear relationship between clinical and pathological signs seen with 
serotype 9 data in Figure 1. In the other two studies, some severely affected pigs were 
necropsied as little as one or two days after infection, while the rest were necropsied 




Figure 9 shows that the relationship between clinical demeanour score and rectal 
temperature is not linear. Once the pigs become mildly ill, increases in either of these 
two indicators of disease severity are more evenly proportional to increases in the 
other. However, healthy pigs also often have rectal temperatures which are measured 
as above `normal', largely due to the stress involved in catching and handling pigs and 
taking their temperatures. This apparent rise in temperature due to handling stress 
should not be construed as being due to an increase in lung pathology. 
Figure 9: 
Mean rectal temperatures plotted against clinical scores 











In each study, infection caused a decrease in feed and water intake, but there was no 
correlation with clinical severity by group. Therefore, although changes in food and 
water intake may be indicative of a disease, there is no apparent relationship between 
clinical signs or severity of pathological change and water or feed intake when 
measured on a group basis. This is possibly a reflection of the dynamics of the group 
and the lessening of competition for food or water for less affected pigs 
in the group. 
It is likely that if individual water or feed intake data could be collected, a relationship 
between increasing clinical and pathological signs and decreasing intake could 
be 
demonstrated, however under commercial situations pigs are housed in groups and 
in 
this situation no clear trend was detected. 
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Table 21a: Spearman's correlation coefficients quantifying the strength of 
correlation between indicators of disease severity in two experimental infections 
of pigs with A. pleuropneumoniae serotypes 3 and 5a 












PUK9501 Rectal temperature -0.13 (0.30) - - - - 
(n=58) * Respiratory score 0.52 (<0.001) 0.11 (0.41) - - - 
% Lung consolidation 0.05 (0.72) 0.10 (0.45) 0.10 (0.44) - - 
Lung/bodyweight ratio (%) -0.04 (0.76) 0.25 (0.06) 0.19 (0.15) 0.71 - 
(<0.001) 
PBE9501 Respiratory score - 0.36 (0.02) - - - 
(n=40) % Lung consolidation - 0.19 (0.24) 0.22 (0.16) - - 
Lung/bodyweight ratio (%) - -0.02 (0.88) -0.03 (0.85) 0.44 (0.005) - 
Bacteriological reisolation - 0.24 (0.14) 0.09 (0.57) 0.32 (0.04) 0.31 (0.05) 
Table 21b: Spearman's correlation coefficients quantifying the strength of 
correlation between indicators of disease severity in an experimental infection of 
pigs with A. pleuropneumoniae serotype 9 
Study Correlation coefficient Clinical Rectal Respiratory % Lung Lung/bodyweight 
(p-value) score temperature score consolidation ratio (%) 
PNE950 Rectal temperature 0.02 (0.87) - - - - 
1 
(n=50) Respiratory score 0.26 (0.07) -0.11 (0.44) - - - 
% Lung consolidation 0.05 (0.72) 0.34 (0.02) -0.06 (0.66) - - 
Lung/bodyweight ratio (%) 0.12 (0.42) 0.33 (0.02) 0.07 (0.62) 0.79 - 
(<0.001) 
Cough score 0.11 (0.45) 0.27 (0.06) 0.06 (0.66) 0.27 (0.06) 0.22 
(0.12) 
Weight gain (%) -0.13 0.37) -0.16 (0.27) -0.07 
(0.64) -0.14 (0.34) -0.18 (0.21) 
Tracheo bronchial lymph 0.29 (0.04) -0.02 (0.88) -0.09 (0.55) 0.06 
(0.67) 0.08 (0.56) 
nodes 
Thoracic lymph nodes 0.18 (0.22) 0.00 (1.00) -0.21 (0.14) 0.13 (0.36) 
0.24 (0.10) 
Sternal aortic lymph nodes 0.26 (0.07) 0.19 (0.19) 0.10 (0.48) 
0.27 (0.05) 0.23 (0.10) 
Cough Weight Tracheo Thoracic Sternal aortic 
bronchial 
score gain (%) lymph nodes lymph nodes 
lymph nodes 
Weight gain (%) -0.08 (0.60) - - - - 
Traclleo bronchial lymph 0.24 (0.09) -0.33 (0.02) - - - 
nodes 
Thoracic lymph nodes 0.16 (0.28) -0.32 (0.02) 0.53 - - 
(<0.001) 
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LABORATORY STANDARD OPERATING PROCEDURE : 
GROWTH OF MYCOPLASMA GALLISEPTICUM R-PIO 
Preparation of the inoculum: At least five days before challenge of chickens, one 
tube from the stock culture of Mycoplasma gallisepticum R-PIO kept at -70°C in 5 ml 
aliquots of mycoplasma FM4 broth containing 10% glycerol (Merck 4094) are thawed 
and inoculated in 4.5 ml of FM4 medium contained in a 15ml glass tube. The culture 
is incubated aerobically at 37°C for 48 to 72 hours until the colour of the medium 
changes from pink to yellow. Then two 250 ml glass flasks containing 50m1 of FM4 
medium are inoculated with 2 ml of the culture and incubated aerobically at 37°C for 
24 hours until the colour of the medium becomes yellow. 
Storage of the inoculum: the inoculum is stored at 5±3°C until inoculation. 
Titration of the culture: before and after inoculation of the chickens, tenfold 
dilutions of the suspension are made in FM4 medium and incubated aerobically in 
5m1 plastic tubes at 37°C to determine the concentration of the suspension (Rodwell 
and Whitcomb, Methods in Mycoplasmology 1: 185-196,1983). 
Control medium: A control FM4 medium is prepared and consists of tubes and 
flasks containing sterile medium incubated under the same conditions. This sterile 
medium is used to inoculate non-infected control birds. 
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LABORATORY STANDARD OPERATING PROCEDURE : 
RECOVERY OF MYCOPLASMA GALLISEPTICUM R-PIO 
Approximately one centimeter of the distal third of the trachea is sampled from every 
dead or euthanased chicken and placed in a plastic sterile tube containing 1 ml of 
transport medium. Each tube is identified with the chicken number. Tubes are 
maintained at 5±3 °C until the day of culture (not later than 72 hours later). 
In the laboratory, all work is done under a laminar flow hood. 
From each sample, an aliquot of I Oµ1 is used to inoculate an FM4 agar plate and an 
aliquot of 0.250m1 is used to inoculate 0.75m1 of FM4 broth contained in one 5m1 
plastic tube (TO tube). Two tenfold dilutions are made from TO into FM4 medium. 
The three tubes (labelled TO, T-1 and T-2) and the agar plate are incubated 
aerobically at 37°C. Ten ml of broth are sub-cultured onto mycoplasma FM4 agar 
when there is a colour change. If no tube has changed colour after one week of 
incubation, l0µ1 of suspension from tube TO are seeded onto FM4 agar. All agar 
plates are incubated for 21 days and observed twice a week for the presence of 
mycoplasma colonies. 
Identification of two isolates per replicate is performed according to their biochemical 
properties (metabolism of glucose and arginine, phosphatase activity and tetrazolium 
reduction). 
153 
TRANSPORT MEDIUM FOR MYCOPLASMA 
Buffered peptone water (Merck 7228) 25.5g 
Glycerol (Merck 4094) 12m1 
Distilled water 1 litre 
Adjust pH to 7.4-7.6 
Sterilise by autoclaving 20 minutes at 121 °C. 
Aseptically add: 
Specillin G: 106 IU 
Thallium acetate (Merck 12635) filter-sterilized: 0.5g 
The transport medium may be stored up to one week at 5°C±3°C or up to one year at 
-20°C 
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LABORATORY STANDARD OPERATING PROCEDURE : 
SLIDE AGGLUTINATION TEST 
FOR MYCOPLASMA GALLISEPTICUM SEROLOGY 
Sera from 20 one-day old chicks and from all birds necropsied on day 21 were tested 
for Mycoplasma gallisepticum agglutinating antibodies, according to the method 
described in: 
Nougayrede P., Toquin D., Andral B. and Guittet M. Avian Pathology, 13,753-768. 
Mycoplasma gallisepticum antigen were obtained from Intervet. 
Sera are first tested undiluted. Positive sera are then retested after being heated for 30 
minutes at 56°C and diluted 1: 5 with phosphate-buffered saline (PBS) pH 7. Those 
that still react are considered positive. Sera that react only when undiluted are 
considered as as uncertain results. 
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INOCULATION OF BIRDS 
On day 10 of life, birds are individually inoculated with a Mycoplasma gallisepticum 
culture prepared according to SOP "Growth of Mycoplasma gallisepticum R-PIO" . 
Each bird is inoculated with 0.2 ml intra-tracheally and with 0.05 ml into the right 
sinus. 
Material requirements for intra-tracheal inoculation include a good source of light, 
IMI pipets equipped with thin tips and paper towels. 
For intratracheal inoculation when the glottis is opened, the pipet is inserted into the 
trachea and the bird is inoculated. 
Material for inoculation into the sinus include PIOO Pipetman with appropriate sterile 
tips. The bird is held on its left side, on a table 0.05m1 of culture is inoculated into the 
right nostril. The birds are maintained in this position until the drop disappears. 
Control (non-inoculated) birds are similarly inoculated with sterile FM4 broth. 
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STATUS OF SPECIFIC-PATHOGEN-FREE 
CHICKS 
Specific-pathogen-free chicks (SPF) are obtained from SPF flocks 
These flocks are repeatedly tested to ensure freedom from the pathogens listed below: 
Avian adenovirus 
Avian reovirus 
Avian encephalomyelitis virus 
Infectious Bronchitis virus 
Gumboro (Infectious Bursitis) virus 
Avian orthomyxovirus (type A) 
Avian infectious laryngotrachyitis virus 
Marek's Disease virus 
Newcastle Disease virus (Avian paramyxovirus type 1) 





EXPERIMENTAL ANIMAL, HOUSE 
The Experimental Animal House was purpose-built for the housing of poultry in 
isolation for experimental work and for the containment of pathogens. Appropriate 
measures are taken to prevent access of rodents, wild birds, insects and unauthorised 
people. The building is supplied with a filtered air supply, performed by one single 
high efficiency particulate air filtration system (HEPA 99.9% efficacy) on the inlet 
supply and three HEPA filters on the extraction system. The building includes 16 
animal rooms, 25m2 each, light-, temperature- and ventilation-controlled. Each room 
is equipped with an air-lock chamber and with a shower-through entry system. Birds 
are housed in filtered air under positive or negative pressure according to their status 
(SPF birds or infected ones). Each room is also equipped with two HEPA filters on 
the inlet supply and three HEPA filters on the extraction system. 
Before entering a non-infected room, personnel shower in the air-lock chamber and 
change clothing (including, hair protective clothing) and shoes. Before entering an 
infected room, clothes are changed in the lock chamber and, after visiting infected 
birds, it is necessary to shower in the air-lock chamber. Contaminated clothes remain 
in the contaminated room. 
Items taken into the room are sterilised or put in plastic bag before entering the room. 
Food is sterilized by granulation, and is wrapped up in plastic bag and paper bag. The 
bag is carried to the experimental animal house where it is fumigated after elimination 
of the paper bag. 
Drinking water is tap water, heated to 80°C and then cooled. 
After completion of a trial, rooms are cleaned and sanitized. All feed and equipment 
is fumigated into the animal room. Litter, feed and carcases are incinerated within the 
building and liquid waste is treated with sodium hydroxide. 
Chickens are kept in two batteries of cases on three decks and two rows. Ten birds 
are kept in each cage. 
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